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SUMMARY
Biochemical studies have shown that divalent cations 
modulate adenosine receptor binding. In this 
electrophysiological study the effect of calcium on the 
postsynaptic sensitivity to adenosine was investigated.
Extracellular recordings were made in the CA1 
pyramidal cell layer of rat hippocampal slices following 
orthodromic stimulation of Schaffer collateral fibres in the 
stratum radiatum or antidromic stimulation of the alveus. 
Field excitatory postsynaptic potentials (fEPSPs) were 
recorded in stratum radiatum. In antidromic stimulation 
experiments, CaC^ was omitted (calcium-free medium) or 
reduced to 0.24 mM (low calcium medium) and in some 
experiments MgSO^ was increased to 2 mM or 4 mM.
Adenosine and baclofen induced a concentration- 
dependent reduction in the amplitude of orthodromic 
potentials with maximum effects at 20 and 5 pM , 
respect ively.
2+In nominally Ca free medium, multiple population 
spikes were obtained in response to antidromic stimulation. 
Adenosine had little effect on reducing the secondary spike 
amplitude. Kynurenic acid, an excitatory amino acid 
antagonist, at high concentration had no effect on 
secondary spikes in calcium-free or low calcium medium.
2-Chloroadenosine (1-500 pM) and R-PIA (50 pM), which 
are not substrates for either the nucleoside transporters 
or adenosine deaminase were inactive in the absence of 
calcium. S-(2-Hydroxy-5 nitrobenzyl)-6-thioinosine , an
XVI
adenosine uptake blocker, at a concentration of 100 pM had 
no effect on secondary potential size and did not restore 
adenosine sensitivity in calcium free medium.
Sensitivity to adenosine in calcium-free medium was 
restored by 240 pM calcium medium or by raising magnesium 
(0.8-2.8 mM) . Raising the divalent cations concentration 
increased the inhibitory effect of adenosine and 
desensitisation was seen. Thapsigargin, which discharges 
intracellular calcium stores, at 1 pM had no significant 
effect on the bursts and did not change the effect of 0.5 
mM adenosine in calcium free medium.
Unlike adenosine, baclofen concentration-dependently 
reduced the secondary spike size in calcium free medium and 
at maximum effect (0.5 mM) or above no sign of recovery was 
observed during maintained superfusion for up to 45 
minutes.
The activity of adenosine was restored in the presence 
of the stabilizer agents procaine or carbamazepine, known 
inhibitors of sodium channels. The GABAg agonist baclofen 
did not restore sensitivity to adenosine.
T h e  x a n t h i n e s  t h e o p h y l l i n e  a n d  
cyclopentyltheophyl1ine, the latter of which is selective 
for Aj purine receptors, depressed the excitability of 
hippocampal pyramidal neurones in calcium-free media. 
Chelating residual calcium with EGTA reduced excitability 
which was additive with the xanthine effect, while 100 pM 
calcium depressed the response to theophylline. The 
inhibition by xanthines was prevented by adenosine, which
XVII
had no effect by itself, but was not reproduced or modified 
by adenosine deaminase. The xanthine effects were also 
prevented by baclofen and carbamazepine.
Tolbutamide 1 mM blocked the inhibitory effect of 
adenosine on the size of orthodromic population spikes but 
had no effect on the inhibitory action of adenosine on 
field EPSPs. Tolbutamide did not change the inhibitory 
action of baclofen on the population spikes or antidromic 
secondary spikes induced in calcium-free media with high 
magnesium but dramatically blocked the effect of adenosine 
in the calcium-free media. Levcromakalim 100 pM potentiated 
the inhibitory effect of adenosine, but not baclofen, on 
orthodromic population spikes.
The results of this study showed that the mechanisms 
of postsynaptic activity of adenosine and baclofen are 
different and at postsynaptic, but not presynaptic, sites 
adenosine may activate an ATP-(tolbutamide or 
levcromakalim) sensitive potassium channel. Loss of 
postsynaptic sensitivity to adenosine in calcium-free 
solution may result from increased sodium conductances. 
A common feature of adenosine, baclofen and carbamazepine 
which may account for their antagonism of the xanthines is 
the blockade of calcium fluxes. It is proposed that in the 
presence of low external concentrations of calcium 
xanthines can reduce excitability by promoting the 
mobilisation and trans-membrane movement of residual 
calcium in the medium or neuronal membranes.
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Adenosine has effects on almost all kinds of mammalian 
tissue including the central nervous system. As a 
neuromodulator adenosine has a profound depressant action 
in the central nervous system. The mechanism of adenosine 
action is not fully understood. Its action may be mediated 
pre- and postsynaptically through receptor-mediated 
mechanisms including effects on second messenger systems, 
transmembrane ion fluxes and neurotrransmitter release.
1. HISTORICAL PERSPECTIVE OF ADENOSINE
A definite action of adenosine was first demonstrated 
by Drury and Szent-Gyorgyi (1929). They showed that 
adenosine in extracts of heart muscle and other tissues 
such as brain have a specific action upon the heart. Sattin 
and Rail (1970) later reported an effect of adenosine on 
cAMP accumulation in the CNS. Phillis et a l ., ( 1975) showed 
that adenosine and several adenine nucleotides depressed 
the excitability of cerebral cortical neurones of rat in 
vivo. The depressive effect of adenosine in different areas 
of brain was later demonstrated by Kostopoulos and Phillis 
( 1977). In 1978 Burnstock proposed the terms Pj for the 
nucleoside receptors like adenosine and P2 for the 
nucleotide receptors like ATP (Burnstock, 1990). The 
adenosine receptors were divided by Van Calker et al., 
(1979) into Aj and A2 based on the stimulation or inhibition
2of cAMP. The 1980s witnessed the more detailed
characterization of adenosine receptors. These years were 
also spent elucidating the second messengers by which 
adenosine may act to elicit its array of biological
responses. The 1990s will lead this field into the realm of 
molecular pharmacology, with determination of the amino 
acid sequences for adenosine receptors and ultimately the 
genes coding for these receptors (Cushing & Mustafa, 1991).
2. BIOSYNTHESIS, RELEASE AND INACTIVATION OF ADENOSINE
The two likeliest sources of adenosine are the 
dephosphorylation of 5 '-AMP by 5-nucleotidase and the 
action of S-adenosylhomocysteine hydrolase upon S-
adenosylhomocysteine (Snyder, 1985). Adenosine also as a 
nucleoside of adenine can be synthesized de novo from 5- 
phosphoribosyl-l-pyrophosphate and glutamine (Stone &
Simmonds, 1991).
Adenosine levels in the brain are regulated by the 
balance of energy supply and demand (Meghji, 1991). There 
is equilibrium between the cytoplasmic concentrations of 
ATP, ADP and AMP, and because the ATP concentration in 
resting cells is much more than the AMP concentration, a 
very small percentage fall in ATP concentration can 
increase cytoplasmic AMP concentration substantially, with 
the formation of adenosine (Fredholm, 1987; Stone et al . , 
1990).
The concentration of adenosine is increased several 
times during seizures (During & Spencer, 1992), hypoxia or 
ischaemia (Fowler 1990, 1993a,b; Gribkoff and Bauman,
1992). Chemical agents such as excitatory amino acids or 
veratridine, or electrical brain stimulation can also 
release adenosine (Pedata et al ., 1991; Sciotti et a l .,
1993). Potassium can also evoke a calcium-dependent 
extrasynaptosomal accumulation of endogenous adenosine 
(MacDonald & White, 1985).
Adenosine can be inactivated by uptake into neurones 
and neighbouring cells through a nucleoside transporter by 
a facilitated diffusion process which is largely regulated 
by the concentration gradient for adenosine. It is also 
inactivated either by phosphorylation to AMP by adenosine 
kinase or deamination to inosine by adenosine deaminase 
(Meghji, 1991,1993). Nucleoside transport inhibitors such
as dipyridamole or nitrobenzyl-thioinosine enhance the 
effect of adenosine (Greene & Haas, 1989).
In contrast to the sites and mechanisms of adenosine 
actions, the sites and mechanisms of adenosine formation 
and subsequent release are still subject to much argument 
and controversy (Stone et a l ., 1990). Although released 
extracellular ATP is broken down to adenosine by ecto- 
nucleotidases, blocking of this enzyme was found to be 
without effect on the basal or evoked release of adenosine 
from rat hippocampal slices (Lloyd et a l ., 1993) or
embryonic chick neurones and glia in cell culture (Meghji 
et al . , 1989). It seems adenosine is formed predominantly
intracellularly and released to the extracellular space.
Although adenosine can be taken up by synaptosomes and 
released following depolarization, there is no evidence 
that adenosine is stored in synaptic vesicles and no clear 
cut adenosinergic pathways have been established in the 
brain (Browning, 1992). Adenosine is also poorly released 
by potassium^ from preparations in comparison with 
neurotransmitters and there is difference in time course of 
release between adenosine and neurotransmitters (Stone et 
al . , 1990). Therefore the term neuromodulator may be better 
used for adenosine.
3. ADENOSINE RECEPTORS
A . CLASSIFICATION
The finding of Sattin and Rail ( 1970) that 
methylxanthines, theophylline and caffeine, can block 
effects of adenosine was the first evidence for specific 
adenosine receptors. In 1978 Burnstock divided purine 
receptors into Pj for the nucleoside receptor and Pj for the 
nucleotide receptors (Burnstock, 1990). The Pj receptors are 
most readily characterised as sites at which xanthines act 
as competitive antagonists and adenosine has higher 
affinity than ATP (Stone, 1989, 1991).
5Pj receptors are further subdivided to Aj and Aj based 
on the inhibition or stimulation of adenylate cyclase 
respectively. Adenosine has nanomolar affinity for Aj 
receptors and micromolar affinity for Aj receptors (Van
Calker et al. , 1979). In another study Pj receptors were
subdivided to Ri and Ra for Aj and Aj respectively, the
subscripts of which refer to the inhibition(i) and 
activation(a) of adenylate cyclase activity. R refers to 
the ribose group of adenosine which is necessary for
agonist activity (Londos & Wolff, 1977; Londos et a l ., 
1980). Because some physiological effects of adenosine are 
not mediated via a cAMP-dependent mechanism (Dunwiddie and 
Hoffer, 1980), the general use of the Aj/A  ^ nomenclature 
which does not inherently imply any activation or 
inhibition for adenylate cyclase was recommended (Stone, 
1985). Based on [ H]NECA binding, adenosine Aj receptors are 
also further divided into Aja (high affinity) and Aj^  (low 
affinity) receptors (Bruns et al ., 1986). Both these
subtypes increase adenylate cyclase activity.
There is also a P-site which mediates inhibition of 
adenylate cyclase and requires integrity of the purine ring 
for activity but can tolerate compounds with a modified 
ribose moiety (Londos & Wolff, 1977). Inhibition of 
adenylyl cyclase activity by the P-site action of adenosine 
apparently involves a direct effect on the catalytic 
subunit of adenylyl cyclase. This effect of adenosine 
requires higher adenosine concentrations than needed for A|
6adenosine receptor-mediated adenylyl cyclase inhibition and 
is not blocked by adenosine receptor antagonists. 
Furthermore, some adenosine derivatives, e.g. 
dideoxyadenosine, are specifically active at this P-site. 
Inhibition of adenylyl cyclase via the P-site is most 
efficient when the enzyme is activated (Reithmann et a l ., 
1990) . The physiological role of this inhibitory site is 
still unknown, but recent data indicate that the P-site may 
be a physiological target for 3 '-AMP and related 
nucleotides (Schwabe et al ., 1993).
Besides extracellular (Aj and Aj receptors) and 
intracellular (P-site) adenosine receptors, recently Zhou 
et al. , ( 1992) reported the cloning, expression and
functional aspects of a new adenosine receptor, which they 
called the A^  receptor. They showed this receptor coupled to 
a pertussis toxin-sensitive G protein, and can inhibit 
adenylate cyclase. This receptor is different from an 
earlier proposed A3 site which reported by Ribeiro and 
Sebastiao (1986). The first A^  receptor was based on 
pharmacological tools. The non-selective adenosine receptor 
agonist 5 '-N-ethylcarboxamidoadenosine (NECA) is equipotent 
to the nominally selective A^  receptor ligands 
cyclohexyladenosine (CHA) and R-N^-phenylisopropyladenosine 
(R-PIA), and more potent than 2-chloroadenosine. This
receptor was not linked to adenylyl cyclase but involved
2+inhibition of Ca influx and/or mobilization. The major 
difference between this receptor and the subsequently
cloned receptor is the fact that the latter receptor is not 
sensitive to alkylxanthine antagonists (Carruthers & 
Fozard, 1993a).
B. DISTRIBUTION 
Adenosine Aj Receptor
A quantitative autoradiographic study in the human 
brain showed that Adenosine Aj receptors were 
heterogeneously distributed throughout the brain and 
essentially localized to the gray matter The highest 
receptor densities were found in the stratum oriens, 
pyramidale and radiatum of the hippocampus. High densities 
were also found in the cerebral cortex and the striatum. 
The hypothalamus had low receptor densities (Fastbom et 
al . , 1987). Ex vivo autoradiographic distribution of
[ H]DPCPX in brain also showed high levels of adenosine Aj 
receptor in tissues like cerebellum and hippocampus and a 
lower density in brain stem or hypothalamus (Bisserbe et 
al., 1992).
Combining binding and autoradiographic procedures with 
different lesion methods such as transient ischemia, 
chemical agents (kainic acid or colchicine) and mechanical 
lesions were used to clarify the exact site of adenosine 
receptors, pre- or postsynaptically (Deckert & Jorgensen, 
1988; Dragunow et al., 1988; Onodera & Kogure, 1988). Using 
lesioning techniques and autoradiographic methods in rat
hippocampus it was demonstrated that adenosine Aj receptors 
were localized on the terminals of the perforant path 
(Dragunow et al. , 1988). With similar techniques Onodera
and Kogure (1988) showed adenosine Aj receptors in the CA1 
and CA3 subfields of rat hippocampus, located predominantly 
on intrinsic pyramidal cells. The results of Deckert and 
Jorgensen (1988) showing that adenosine Aj receptors are 
located presynaptically and postsynaptically are more 
consistent with the electrophysiological study of Thompson 
et al., (1992) that adenosine acts at pre- and postsynaptic 
receptors which are pharmacologically indistinguishable.
Adenosine A2 Receptors
With the autoradiographic study of distribution of 
[ H]CGS21680, which binds more to A2a adenosine receptors, 
it was shown that this receptor is highly concentrated in 
striatum, nucleus accumbens and olfactory tubercle of rat 
brain. Lower levels of binding were also found in the 
globus pallidus. No significant amounts of specific ligand 
binding were observed in any other brain region (Jarvis & 
Williams, 1989). A similar result was also reported in 
human and rat brain by binding assay. Low binding of the A2 
agonist was found in cerebellum and hippocampus (Wan et 
al., 1990). A2b adenosine receptors are distributed widely 
throughout brain tissue (Bruns et al., 1986).
Adenosine Aj Receptor
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There are limited studies about adenosine A3 receptors. 
There was relatively low expression of this novel receptor 
in the central nervous system but high expression was 
observed in testis (Zhou et al . , 1992).
C. LIGANDS FOR ADENOSINE RECEPTORS
Many agonist ligands for the adenosine Aj receptor have 
been investigated over the past 30 years. These include the 
N6-subsituted analogues cyclohexyladenosine (CHA), 
cyclopentyladenosine (CPA), phenylisopropyladenosine (PIA) 
and 2-chloroadenosine (2CADO, Williams et al., 1986;
Williams, 1987; Williams and Cusack, 1990).
There has been less success in developing k^  adenosine 
ligands. For a period of time, the 5-substituted adenosine 
analogue, 5'-N-ethylcarboxamidoadenosine (NECA) was used to 
define tissue responses mediated by k^  receptor activation. 
However, this ligand is non-selective and approximately 
equipotent at both Aj and A  ^ receptors. A recently produced 
compound, CGS21680 is 70-140 fold selective on k^ receptors 
in binding assays (Williams , 1991). At present for the A3 
receptor N^-2-(4-aminophenyl)ethyladenosine (APNEA) is the 
most useful agent for activation of this receptor 
(Carruthers & Fozard, 1993b & c; Fozard & Carruthers, 
1993a).
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The agonist potency orders for different adenosine 
receptors are:
: CPA>R-PIA=CHA>NECA>2CADO>S-PIA 
A2a: CGS21680=NECA>2CADO>R-PIA=CHA=CPA>S-PIA 
A2b: NECA>2CADO>R-PIA=CHA>S-PIA>CGS21680 
A3: APNEA>R-PIA=NECA>CGS21680 (Collis & Hourani, 1993).
The most famous antagonists at adenosine receptors are 
theophylline and caffeine which share a xanthine structure. 
These agents can not discriminate between Aj and A2 
adenosine receptors (Daly et al., 1981; Fredholm & Persson 
1982; Stone and Simmonds, 1991). 8-phenyl substituted 
xanthine molecules like 8-phenyltheophyl1ine show more 
selectivity for Aj receptors. Alterations in the 
substituents at the 1- and 3- positions alter both the 
activity and pharmacological selectivity of the xanthines. 
1,3-Diethyl-8-phenylxanthine(DPX) is a potent Aj antagonist 
with 18-fold selectivity. The cyclopentyl xanthine, 8- 
cyclopentyl-1,3,-dipropyl xanthine (CPX or DPCPX) has 
subnanomolar affinity for the Aj receptor and is 740-fold 
selective. Cyclopentyltheophyl1ine (CPT) is 130-fold 
selective for the Aj receptor (Williams, 1991). CPT is 40 
times more soluble than DPCPX (Bruns et al., 1987).
There is not any selective A2b adenosine receptor 
ligand available. There are a few A2a antagonists such as 8- 
(3-Chlorostyryl)caffeine (CSC) which is 520-fold selective 
for this receptor (Jacobson et al., 1993a).
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Recently, an receptor antagonist, 3-(3-iodo-4-
aminobenzyl)-8-(4-oxyacetate)-1-propylxanthine (BW-A522) 
has been introduced which blocked adenosine A3 receptor- 
mediated hypotensive responses in the rat (Fozard & Hannon, 
1994) .
D. FUNCTIONAL EFFECTS OF ADENOSINE RECEPTORS
Generally adenosine has depressant actions in the 
hippocampus (Dunwiddie & Hoffer, 1980; Dunwiddie et al. , 
1991; Lee & Schubert, 1982; Schubert & Mitzdorf, 1979), 
cerebral cortical neurones (Phillis et a l ., 1975),
olfactory cortex (Collins & Anson, 1985; Motley & 
Col 1 ins,1983 ; Scholfield , 1987), and different areas of
brain (Kostopoulos and Phillis 1977). There are a few 
reports such as those of Okada and his colleagues which 
suggest that adenosine has excitatory effects in guinea pig 
hippocampal slices with concentrations of 1 pM or below 
(Nishimumura et al., 1992; Okada, 1991; Okada et al.,
1992).
The Aj and Aj receptors mediate somewhat different 
effects in most tissues. Aj adenosine receptors have 
inhibitory action (Alzheimer et al. , 1991; Dunwiddie et
a l ., 1984; Sebastiao et al., 1990). In guinea pig
hippocampal slices, the highly adenosine Aj receptor 
selective antagonist, DPCPX, produced parallel, rightward 
shifts of the concentration-response curve for CPA-induced
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decreases in orthodromically evoked population spikes of 
CA1 neurones (Alzheimer et al., 1991).
An increasing volume of data indicates that excitatory 
actions of adenosine, such as depolarization and an 
enhancement of transmitter release, can be mediated by A2 
receptors (Ameri & Jurna, 1991). There are some reports 
that A2 receptor agonists have inhibitory effects. The A2 
selective adenosine receptor agonist CGS21680 depressed the 
spontaneous, acetylcholine- and glutamate-evoked firing of 
rat cerebral sensorimotor cortical neurons (Phillis, 1990). 
In rat hippocampal slices, CGS21680 decreased the EPSP size 
in CA1 . This A2 agonist did not increase cAMP levels in the 
hippocampus but in the striatum it enhanced cAMP levels 
two-fold. Therefore this agonist may act at an Aj adenosine 
receptor in hippocampus to show the inhibitory effect 
(Lupica et al ., 1990). Sebastiao and Ribeiro (1992) showed 
that nonomolar concentrations of CGS21680 reversibly 
increased in a concentration-dependent manner the amplitude 
of orthodromically-evoked population spikes recorded from 
the CA1 pyramidal cell layer of rat hippocampal slices. 
Thus it seems the inhibitory effect of this agent may be 
related to actions on Aj receptors at high concentration. By 
intracellular recording in rat hippocampus, Ameri and Jurna 
(1991) demonstrated that R-PIA and NECA at high 
concentration affected membrane properties and showed 
excitatory effects. Theophylline, non-selective for 
adenosine receptors, blocked this effect but DPCPX, an Aj 
selective antagonist, was ineffective.
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E. ALLOSTERIC ENHANCERS
Recently, a new class of compound has been shown to 
enhance adenosine receptor binding. These compounds 
originated from a series of 2-mino-3-benzoy1-thiophenes. 
PD81,723 enhanced the inhibitory effect of exogenously 
applied adenosine, with no effect alone, in hippocampal 
brain slices (Janusz et al., 1991). In another study, this 
group showed that in low magnesium-induced bursting, which 
induces adenosine release, this agent alone reduced the 
duration of epileptiform bursting (Janusz & Berman, 1993).
4. PRESYNAPTIC ACTIONS OF ADENOSINE
There is abundant documentation that adenosine 
diminishes transmitter release via an action at the 
presynaptic terminal. Adenosine or adenosine analogues 
inhibit release of glutamate (Fastbom & Fredholm, 1985; 
Burke & Nadler, 1988), acetylcholine (Fredholm, 1990; 
Jackisch et al., 1984; Kirkpatrick & Richardson, 1993),
noradrenaline (Allgaier et al ., 1987; Jonzon and Fredholm, 
1984), dopamine (Jin et al. , 1993; Michaelis et al . , 1979), 
GABA (Hollins and Stone, 1980) and serotonin (Feuerstein et 
al . , 1988) in the central nervous system. Adenosine also
peripherally inhibits release of neurotransmitters such as 
acetylcholine (Nagano et al ., 1992).
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The potency of adenosine on inhibition of
neurotransmitter release in the different areas of brain 
and for each transmitter is different. For example 
adenosine depressed GABA release about 35 percent in
cerebral cortex only with high concent rat ion, |l mM (Hollins 
and Stone ,1980). Attempts by Fredholm and Jonzon 
(unpublished data in Dun&r-Engstrom and Fredholm, 1988) to 
demonstrate that adenosine analogues inhibit GABA release 
were unsuccessful. The effect of adenosine on noradrenaline 
release is also much less (Hu and Fredholm , 1989). It
seems adenosine is a more potent inhibitor of release of 
excitatory than inhibitory neurotransmitters. This may be 
consistent with the idea adenosine receptor are located on 
excitatory terminals (Lambert and Teyler, 1991; Thompson et 
a l ., 1992; Yoon and Rothman, 1991).
The mechanism of inhibitory effect of adenosine on 
transmitter release is not completely clear. Transmitter 
release is largely dependent on calcium influx into nerve 
terminals and the mobilization of intracellular calcium 
(Sihra & Nichols, 1993; Zucker, 1993). Therefore one
possible mechanism of adenosine to inhibit transmitter 
release may be blocking of the calcium influx or an effect 
on the calcium sensitivity of the release process.
2+Inhibitoryeffect(s)of adenosine on Ca influx are 
controversial. There are some positive effects of adenosine 
on the uptake of labelled ^Ca into synaptosomes. In rat
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brain synaptosomal preparations, adenosine modulated 
calcium uptake by potassium depolarized nerve terminals
(Ribeiro et al., 1979; Wu et al., 1982). Adenosine
analogues decreased calcium uptake across voltage sensitive
calcium channels slightly in both synaptosomes and
hippocampal slices (Bartrup, 1989). By contrast, other 
laboratories reported adenosine and adenosine analogues had 
no effect on calcium uptake by potassium or veratridine 
depolarization (Barr, 1985; Garritsen et al. , 1989;
Michaelis et al., 1988). -
2-Chloroadenosine decreased calcium currents in 
cultured rat hippocampal pyramidal or dorsal root ganglion 
neurones under whole-cell voltage clamp (Dolphin et a l . , 
1986; Scholz & Miller, 1991a). The effect of adenosine 
analogues was relatively weak in these experiments. In 
acutely isolated pyramidal neurones from the CA3 region the 
calcium channels which were blocked by activation by 
adenosine Aj agonists were of the N-type (Mogul et al. ,
1993). Scanziani et a l ., (1992) reported that in the
presence of cadmium, which did not change either frequency 
or amplitude of miniature synaptic currents, adenosine and 
baclofen decreased the frequency of miniature synaptic 
currents of organotypic hippocampal slice cultures. They 
concluded that the reduction in synaptic strength was not 
by reduction of postsynaptic sensitivity to 
neurotransmitter and that the reduction of presynaptic 
glutamate release by adenosine and baclofen was not
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2+ • 2+ mediated by inhibition of a Cd -sensitive presynaptic Ca
current.
With ion sensitive microelectrodes it was shown that 
adenosine decreased pre- and postsynaptic calcium signals 
of rat hippocampal cells in low calcium medium (Schubert et 
a l ., 1986). In another report Schubert (1988) demonstrated 
that endogenous adenosine also, via Aj receptors, inhibits 
calcium influx in the synaptic and pyramidal cell soma 
layer in the CA1 area of rat hippocampal slices. However 
they did not clearly indicate into which compartment, 
neuron or glia, calcium moves.
Silinsky (1986) proposed adenosine impairs transmitter 
secretion by reducing the affinity for calcium at a site 
beyond the external orifice of the calcium channel. He
speculated on possibilities such as that adenosine may
2 +reduce a Ca -dependent docking of synaptic vesicles or
reduce the affinity of calcium binding protein for alkaline
2+earth cations. Then Ca would not be as effective in 
reducing the electrostatic energy barrier between terminal 
membrane and the vesicles containing neurotransmitters and 
transmitter release would be impaired.
Another possibility for inhibition of calcium current 
is adenosine-evoked inhibition of calcium current may have 
resulted from a shunt of the calcium current secondary to 
the adenosine-evoked increase in potassium currents (Gerber 
et al . , 1989; Greene and Haas, 1989).
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The reasons for the difference of results might be 
related to different nerve terminals, species, or.age, but 
it is also possible that different mechanisms co-exist in 
one and the same nerve terminal and that the relative
importance of these mechanisms will vary depending on , for
example, how the transmitter release is induced (Fredholm 
& Dunwiddie, 1988).
5. POSTSYNAPTIC ACTIONS OF ADENOSINE
There is a relatively large amount of evidence that 
adenosine hyperpolarizes postsynaptic cells via potassium 
channels. Adenosine hyperpolarized CA1 neurones of rat 
hippocampus and decreased input resistance in normal and 
low calcium medium when synaptic activity was blocked.
Adenosine also suppressed excitatory postsynaptic 
potentials (EPSP), by a presynaptic effect, without any 
effect on resting membrane potential (Segal , 1982). Okada 
and Ozawa (1980) also showed a hyperpolarizing action of 
adenosine in guinea pig hippocampal slices.
In more precise experiments, using the patch clamp
technique, Trussell and Jackson (1985) also confirmed that 
adenosine can activate potassium channels in postsynaptic 
neurones from rat striatum. The same group also showed this 
effect in hippocampus and implicated a G-protein in the 
activation of potassium channel (Trussell & Jackson, 1987). 
In single voltage clamp, adenosine evoked or increased
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three potassium conductances: 1) dependent on calcium and
voltage, 2) dependent on calcium only and 3) insensitive to 
both and not inwardly rectifying (Haas and Greene, 1988). 
Adenosine at low concentration (10 (iM) increased the after­
hyperpolarization (AHP) induced by a burst of action 
potentials with no effect or little effect on the resting 
membrane potential. Increasing concentrations of adenosine 
to 50 iiM often decreased AHP and input resistance and 
induced direct hyperpolarization. Tetraethylamonium (TEA), 
a blocker of delayed outward rectification, and 4-AP 
(blocker of transient outward rectification) had no effect 
on adenosine action (Greene and Haas, 1985; Gerber et al .,
1989). Recently Li and Henry (1992) suggested that 
adenosine induces opening of potassium channels in the 
postsynaptic membrane of CA1 rat neurones, including 
channels. Gl ibenclamide, a blocker of KATp, reversibly 
depressed the 2-chloroadenosine-induced hyperpolarization 
and the increase in membrane conductance.
These inhibitory postsynaptic action(s) may be mediated 
by Aj adenosine receptors (Alzheimer et al. , 1989b, 1993;
Dunwiddie & Fredholm, 1989).
Besides acting on potassium, adenosine via an Aj 
adenosine receptor and pertussis-sensitive effect can 
induced a steady-state inward current by a voltage- 
dependent chloride conductance in cultured hippocampal 
neurones. This current was blocked by application of DIDS,
19
a putative Cl" channel blocker (Mager et a l . , 1990). However 
other groups, examining reversal potentials, have reported 
postsynaptic effects of adenosine in hippocampal neurones 
which involve a chloride-insensitive hyperpolarization 
(Gerber et al. , 1989; Okada & Ozawa, 1980; Segal, 1982;
Trussell & Jackson, 1985).
6. POST-RECEPTOR MECHANISM OF ADENOSINE
A . G PROTEIN
GTP-binding proteins are closely related proteins 
which transduce extracellular signals into effector 
responses such as ion channels, adenylate cyclase and 
phospholipase C (Dunlap et al., 1987).
In whole-cell patch-clamp, adenosine evoked an outward 
potassium current in cultured mouse hippocampus and 
striatum and in low-resistance patch electrodes lost its 
action. GTP in the patch electrode filling solution 
restored the adenosine effect. Thus a G protein is involved 
in the coupling between the adenosine receptors and a 
potassium channel (Trussel and Jackson, 1987). This 
potassium channel mediates postsynaptic effects of 
adenosine and is sensitive to barium and coupled to a 
pertussis toxin-sensitive GTP binding protein ( Thompson et 
al., 1992).
The involvement of pertussis toxin-sensitive G 
proteins in the inhibitory effects of adenosine on 
neurotransmission is stiil a matter of controversy. N- 
Ethylmaleimide, a G protein inactivator, decreased 
adenosine inhibition of the release of acetylcholine 
(Fredholm, 1990) and noradrenaline (Allgair et al. , 1987)
evoked by electrical pulses in hippocampus slices. 
Pertussis toxin also reversed adenosine inhibition of 
neuronal glutamate release from cerebellar neurones 
maintained in primary culture (Dolphin & Prestwich, 1985). 
Using whole-cell patch-clamp techniques, the effect of 2- 
chloroadenosine on calcium current was abolished by pre- 
incubation of cultured cells with pertussis toxin (Scholtz 
& Miller, 1991a). However, in area CA3 of organotypic 
hippocampal slice cultures, Thompson et al., (1992) showed
that the effect of adenosine on field excitatory 
postsynaptic potentials (fEPSPs) was not sensitive to the 
toxin. The adenosine-mediated hyperpolarization and 
decreased input resistance as well as the adenosine- 
mediated inhibition of low calcium-induced bursting in 
pyramidal CA1 neurones were virtually abolished by 
injection of pertussis toxin intraventricularly close to 
the hippocampus 48-60 hour before experiment. The 
inhibitory effect of R-PIA on tritiated noradrenaline and 
acetylcholine release evoked by field stimulation in 
hippocampus slices was affected hardly or not at all by the 
toxin treatment. PTX pretreatment also had no effect on 
adenosine inhibitory effects on evoked potentials in the
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CA1 region. This strongly suggests that closely similar Aj 
receptors might be coupled to G proteins that differ in 
their sensitivity to PTX treatment (Fredholm et al. , 1989).
They are some reports of direct coupling of adenosine 
receptors to G proteins. Marala and Mustafa (1993) 
demonstrated the coupling of Aj-adenosine receptors to Gg 
protein in bovine striatum using a combination of 
techniques including agonist-induced tritiated GDP release 
and the blockage of the agonist-stimuTated adenylate 
cyclase activity by Gsa antibody.
Interactions of adenosine receptors with different 
effectors such as ion channels or adenylate cyclase via G 
proteins is not clear. The more probable interaction is 
that adenosine act at one type of receptor, which couples 
with different G proteins, each of which interacts with a 
different effector (Fredholm and Dunwiddie, 1988; Dunwiddie 
& Fredholm, 1989).
B. CYCLIC AMP
Although the original classification of adenosine 
receptors was based on the changing cAMP level (Londos et 
a l ., 1980; Van Calker et a l ., 1979) the functional role of
this second messenger in relation to adenosine in CNS is 
not clear.
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Raising [cAMP]i either with bath applied forskolin or 
8-bromo cAMP did not change the adenosine-evoked potassium 
outward current in the hippocampus and striatum and as 
mentioned above the potassium channel was coupled via a G 
protein (Trussel and Jackson, 1987). In rat hippocampal 
slices, application of PbC^, which has a disruptive effect 
on adenylate cyclase, had no significant effect on 
depressant responses to adenosine. Isoprenaline, which 
increases the cyclic AMP levels, had no effect on the 
amplitude -of adenosine-mediated depressant responses, 
whereas noradrenaline potentiated very modest inhibitory 
effects of adenosine. Thus, adenosine-mediated cyclic AMP 
accumulation can be either inhibited or facilitated without 
markedly affecting the electrophysiological responses to 
adenosine; this suggests that accumulation of cyclic AMP is 
not directly involved in such responses ( Dunwiddie & 
Fredholm, 1985) .
Some physiological responses to Aj receptor stimulation 
are mediated by the inhibition of adenylate cyclase and 
subsequent lowering in intracellular cAMP level. The Aj 
receptor-mediated anti1ipolytic effect in adipocytes and 
the negative inotropic effect in ventricular myocytes are 
two good examples of this mechanism (Green, 1991).
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C. PHOSPHATIDYL INOSITOL TURNOVER AND CALCIUM MOBILIZATION
Adenosine can modulate (decrease or increase) 
phospholipase activity depending upon the animal species, 
the tissue and the nature of activation of this enzyme. 
Adenosine inhibited inositol phospholipid hydrolysis 
elicited in rat cortical slices by mM histamine 
concentrations. This modulation was selective for 
histamine; adenosine has no effect on either basal or 
carbachol-, glutamate-, quisqulate- and noradrenaline- 
stimulated inositol phosphate generation. The rank order of 
potency of adenosine agonists and inhibition of the 
adenosine effect by DPCPX, an Aj receptor antagonist, 
indicated the involvement of Aj receptors (Paoletti et al. ,
1992). Worley et a l ., (1987) also showed a cholinergic
agonist and a phorbol ester could block the inhibitory 
action of baclofen and adenosine in rat hippocampal slice 
preparations via actions on the phosphatidy1inositol 
system.
In peripheral tissue, for example a smooth muscle cell 
line, activation of adenosine Aj receptors causes an 
increase in intracellular levels of inositol 1,4,5- 
trisphosphate and intracellular free calcium in a time- and 
concentration-dependent manner. The effect of adenosine was 
by a pertussis toxin-sensitive G protein (Dickenson & Hill, 
1993; Gerwins & Fredholm, 1992a, b ) .
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D. ARACHIDONIC ACID
The inhibitory actions of adenosine on hippocampus 
responses were unaffected by a phospholipase inhibitor (p- 
bromophenacy1 bromide), lipoxygenase inhibitor 
(nordihydroguaiaretic acid=NDGA) and a cyclo-oxygenase 
inhibitor, indomethacin (Dunwiddie et al. , 1991). The
lipoxygenase inhibitor, NDGA, also failed to antagonize 
adenosine inhibition of the release of acetylcholine evoked 
by electrical pulses (Fredholm, 1990).
7. THERAPEUTIC ASPECTS OF ADENOSINE
In the CNS, the potential therapeutic uses of 
adenosine consists of: anti-convulsant (Dragunow, 1988),
anti-ischaemic (Kolvenbach, 1993; Mori et al. , 1992;
Rudolphi et al. , 1992), neuroprotective (MacGregor & Stone,
1993a, b) , Parkinson’s disease (Lau & Mouradian, 1993), 
antipsychotic, anxiolytic, sedative, analgesic and 
Alzheimer’s disease (Daval, 1991; Williams, 1990, 1993;
Williams & Cusack, 1990). The failure of existing entities 
and the perceived disadvantages of classical medicinal 
chemical approaches for adenosine receptor drugs has led a 
number of laboratories to produce prodrugs, and indirect adenosine 
agonists such as adenosine uptake blocker and allosteric 
enhancers (Jacobson et al. , 1991). The anticonvulsant
action of adenosine will be explained in more detail 
relative to other potential therapeutic effects of 
adenosine here because of the relation to this study.
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Adenosine can prevent seizures in vivo (Dragunow et 
al . , 1985; Murray et al. , 1985, 1993; Whitcomb et a l . ,
1990; Young & Dragunow, 1994), in slices in vitro (Ault & 
Wang, 1986), and in human models (During & Spencer, 1992; 
Kostopoulos et al. , 1989). It is effective in chemical
seizure models such as bicuculline (Ault and Wang , 1986;
Thompson et al. , 1992), high potassium and/or penicillin
(Dunwiddie , 1980; Frank et a l ., 1988) low calcium (Lee et 
al . , 1984; Dunwiddie and Fredholm 1989), kainate,
picrotoxin (Williams, 1987), pentylentetrazole (Murray et 
al ., 1985), strychnine; as well as electrically evoked and 
audiogenic seizure models (Dragunow, 1988).
In cultured rat hippocampal slices, adenosine at very 
low doses (30 nM-1 pM) decreased the frequency or blocked 
spontaneous epileptiform bursting produced by bicuculline. 
However, much higher concentrations of adenosine (50 pM) 
were required to fully block stimulus-evoked events 
(Thompson et al., 1992).
There is a belief that endogenous adenosine also 
exerts an anticonvulsant action. Adenosine antagonists like 
theophylline or adenosine deaminase increased burst 
frequency. Thus an endogenous release of adenosine may 
contribute to the termination of epileptic bursts. 
(Dragunow et al. , 1985; Dunwiddie, 1980; Murray et al . ,
1993). In guinea pig hippocampal slices, a transient and 
selective block of Aj receptors by DPCPX initiates, probably
by modulation of a second-messenger system, a self- 
sustaining process leading to persistent epileptiform 
activity in area CA3 (Alzheimer et al . , 1989b, 1993).
However, in cultured rat hippocampal slices, Thompson et 
a l ., (1992) could not show any tonic effect of adenosine.
DPCPX had no effect on the amplitude of control synaptic 
responses and only when there were bursts by another agent, 
bicuculline, did this Aj antagonist increase burst 
frequency.
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8. CALCIUM
Ions and other constituents of brain slice bathing 
medium, ACSF (Artificial Cerebrospinal Fluid), have been 
designed to maintain metabolic activity and 
electrophysiological function of slices. Any change of this 
environment may dramatically alter the excitability of the 
slice. Calcium is one of these ions which is particularly 
relevant to the present thesis.
9. FUNCTIONAL ROLES OF CALCIUM
A. NEUROTRANSMISSION
One of the main roles of calcium in neurones is to 
support neurotransmission and neurotransmitter release.
Depolarization of the nerve terminal leads to the influx of
2+calcium through voltage-sensitive Ca -channels, which 
trigger the release of neurotransmitter by exocytosis of 
intraterminal vesicles in which the neurotransmitter is 
stored (Sihra & Nichols, 1993). Calcium not only triggers 
exocytosis, but seems to mobilize secretory granules to 
release sites (Zucker, 1993).
B. CALCIUM-DEPENDENT ION CHANNELS
Calcium can activate different ion channels. Three
2 +broad categories of Ca -dependent channels can be
28
distinguished on the basis of ion selectivity: those
selective for K+, for monovalent cations, or for chloride 
(Cl ) ions (Marty, 1989). The first group (calcium-activated 
K+ channels), which have been more extensively studied 
(Blatz & Magleby, 1987; Leinders et al., 1992; Meech, 1978; 
Schwartz & Passow, 1983), will be discus^edunder the
potassium channel classification. Calcium can activate 
channels which are not selective for cations (calcium- 
activated non-specific cation channels) and which appear to 
be a unique class of channels with an important role in 
excitat ion-secret ion coupling and in determining neuron
firing patterns (Partridge & Swandulla, 1988). Calcium- 
activated Cl" channels with low conductance have been 
reported in hippocampus and some other neurones. In sensory 
and spinal neurones this channel can generate depolarizing 
after-potentials but its function in hippocampus is not
clear (Brown et al., 1990a).
C. STABILIZING ACTION
The stabilizing action of calcium emerged from the fact 
that removal of calcium caused an increase in sodium and 
potassium conductance and increased excitability 
(Frankenhaeuser & Hodgkin, 1957). Calcium can organize 
cationic lipids, within the external layer of the membrane, 
into laminar micellae (closed form). These laminar micellae 
may be shifted into globular ones possessing anionic 
properties by potassium (open form). Modifications in the
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membrane selective permeability depend on the structural 
state of the membrane and may therefor rely on the ratio of
i 0 4
K /Ca in the extracellular space (Agrigoroaei & Neacsu,
1990) . Divalent cations including calcium have large 
effects on the delayed rectifier potassium channels. These 
ions may stabilize a closed conformation of the channel and 
their absence may remove the selectivity of the channel 
(Begenisich, 1988).
Omitting calcium from the extracellular medium removes 
the stabilizing action of calcium on the- cell membrane and 
bursts of action potentials appear (Agopyan & Avoli, 1988; 
Haas & Jefferys}1984). The mechanisms involved in this kind 
of burst will be discussed in more detail in the discussion 
sect ion.
D. LTP AND LTD
Calcium is involved in long lasting phenomena 
including long-term potentiation (LTP) or depression (LTD) 
in synaptic plasticity. LTP and LTD, which have been more 
studied in the hippocampus and cerebellum respectively, 
have a key role in memory. LTD has an important role in 
memory elements of cerebellar motor learning. Besides 
glutamate receptors, calcium is involved in the molecular 
mechanisms of LTP and LTD. Injection of the calcium 
chelator, EGTA, into dendrites of hippocampal pyramidal 
cells or Purkinje cell dendrites in cerebellar slice 
preparations effectively abolished LTP and LTD respectively 
(Ito, 1989).
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E. NEUROTOXICITY
2+The cytosolic concentration of Ca plays a critical 
role in neuronal death during anoxic episodes, or during 
sustained exposure to glutamate. In cell cultures of rat 
hippocampus, Ogura et a l ., (1988) have shown that there is 
a correlation between the extent of neuronal loss and
intracellular calcium elevated by glutamate. A sustained
2+increase of cytosolic Ca concentration, is due at least in part to
2±
a suppression of the Ca extrusion from the cell (in
particular via Na /Ca* exchange) rather than from a
2+persistent increase in Ca permeability of the neuronal
membrane (Khodorovet al., 1993). Depletion of intracellular
2+stores of Ca or blocking of internal calcium stores
2+revealed that at least 50% [Ca ]j may be involved in NMDA 
receptor-mediated neurotoxicity in cultured rat cortical 
and retinal ganglion cells (Lei et al., 1992).
F. CALCIUM TARGETS
2+In neurons, there are two major classes of Ca targets
in membranes and three in the cytosol. In the membrane,
2+
calcium stimulates Ca -dependent channels and two important
families of membrane phospholipases, which are activated by
2+a rise in [Ca ]jj phospholipase C, which hydrolyses 
phosphatidylinositol phosphates (PIPs), and phospholipase 
Aj, which cleaves fatty acids, including arachidonic acid, 
from the glycerolipid backbone. The three major cytosolic
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2+
targets include protein kinase C, clpain (a Ca -dependent 
protease) and calmodulin (Kennedy, 1989).
10. CALCIUM CHANNELS
Calcium channels play a major role in neuronal
function, in part, because of the important second
2+messenger actions exerted by free intracellular Ca .
Calcium channels in the surface membrane at least can be
2+divided into voltage-dependent Ca -selective channels and
21ligand-gated Ca -selective channels (Faingold, 1992).
2+Voltage-gated (dependent) Ca channels provide an 
essential connection between transient changes in membrane 
potential and a variety of cellular responses. These ion 
channels electrophysiologically have been divided to: L, T, 
N and P-type (Krizanova et al., 1993).
L-type (long-lasting) or high-voltage activated (HVA) 
channels are high activation , slow inactivation and 
sensitive to calcium antagonists (1,4-dihydropyridines such
as nifedipine, phenylalkylamines such as verapamil and
2+benzothiazepines such as diltiazem). L-type Ca channels
2+can thus be distinguished from T - , N- and P-type Ca 
channels, which are generally resistant to calcium 
antagonists. They are found in all excitable tissues and in
many non-excitable cells. L-type calcium channels are the
2 +major pathway for voltage-gated Ca entry in heart and
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smooth muscle, and they help control transmitter release 
from endocrine cells and some neuronal preparations 
(Krizanova et al., 1993; Tsien et al., 1991).
2+T-type (transient) Ca channels are also known as low- 
voltage activated (LVA) calcium channels and can be opened 
by small depolarization from relatively negative holding 
potentials and are rapidly inactivated. There are few, or 
no, specific blockers of T-type channel and the lack of 
high-affinity probes has hindered structural definition. 
These calcium channels are found in a wide variety of 
excitable and non-excitable cells. The most prominent
functions of T-type channels are to support pacemaker
2+activity or Ca entry at negative membrane potentials. In 
neurones they may be responsible for burst firing (Spedding
& Paoletti, 1992; Tsien et al. , 1991). In sensory neurones,
2 +they are sensitive to Ni , but less sensitive to cadmium 
and are resistant to calcium antagonist; in dissociated rat 
CA1 neurones low concentrations of the dihyropyridine 
nicardipine blocked T-type channels.
2 ±
N-type (nsuronal) Ca channels are ’high-voltage 
activated’ and differ pharmacologically from L-type 
channels in being resistant to calcium antagonists and 
largely blocked by o-conotoxin. They are much restricted to 
neurones and have a major role in mediating transmitter 
release (Tsien et al., 1991).
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P-type (Purkinje) channels are a novel class of high-
2+voltage activated Ca channels that are particularly 
prominent in cerebellar Purkinje cells. This kind of 
calcium channel is resistant to calcium antagonists and co- 
conotoxin but sensitive to spider web venom Aga IV (Tsien 
et a l ., 1991).
Receptor systems may be directly linked to channels
2+with some selectivity for Ca under certain conditions. In 
these systems receptor activation rather than voltage- 
dependent activation is the prime trigger, although there 
may be some modulation by voltage. The NMDA-gated channel 
is an example of this kind of calcium channel (Spedding & 
Paole11 i, 1992).
11. CALCIUM RECOVERY (FADE OF CALCIUM)
Intracellular homeostasis of calcium plays an
important role in cell functioning and survival. Cytosolic
2+free Ca is very low in relation to outside. In CA3
pyramidal cells at the holding membrane potential of -50
mv, the intracellular concentration of this ion is about 30 
nM, which increased with reduction of the membrane 
potential to more positive values (Knopfel et al. , 1990).
In general several mechanisms may contribute to the
2+whole process of [Ca ]j recovery: 1) calcium binding by
cytoplasmic proteins and other ligands, representing fast
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calcium buffers; 2) calcium redistribution in the cytoplasm 
by simple diffusion; 3) Na /Ca exchange; 4) calcium pump; 
5) calcium uptake within the cell by mitochondria or 6) by 
endoplasmic reticulum (Kostyuk et a l ., 1989).
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12. POTASSIUM CHANNELS
Potassium ions are selectively concentrated in the 
interior of cells, and the concentrations of potassium in 
the extra- and intracellular fluid are approximately 4 and 
150 mM, respectively. Potassium ions play a dominant role 
in controlling the resting membrane potential in most 
excitable cells and maintain the transmembrane voltage 
positive to the potassium equilibrium potential (E^ ) of 
about -90 mv. During depolarization, sodium ion influx 
causes the transmembrane potential to become more positive 
relative to E^ ; repolarization causes the cell to return 
toward E^  (become more negative) and is mediated in large 
part by the efflux of potassium ions down their 
concentration and electrical gradients (Robertson & 
Steinberg, 1990).
The main function of open potassium channels is to 
stabilize the membrane potential. These channels generally 
lower the excitability of the cell when they are open 
(Hille, 1984). Agents that block potassium channels tends 
to produce membrane depolarization; i.e, they shift the 
transmembrane potential in a positive direction away from 
EK. Compounds which open potassium channels tend to produce 
membrane hyperpolarization and shift the resting membrane 
potential toward E^  (Blatz & Magleby, 1987; Robertson & 
Steinberg, 1990). Such an effect would oppose the opening 
of vol tage — operated calcium (or sodium) channels which
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require depolarization above a certain threshold membrane 
potential for activation (Cook, 1988).
13. CLASSIFICATION OF POTASSIUM CHANNELS
Potassium channels are ubiquitous in eukaryotic cells 
and exhibit more diverse characteristics than channels for 
other ions. Over a dozen types of potassium channels have 
already been identified using variations on the patch clamp 
technique (Faingold, 1992).
Potassium channels are regulated through voltage, 
calcium, G protein and ligands. These ion channels can be 
classified according to functional properties of ion 
selectivity and conductance, gating behaviour, 
pharmacology, and regulation (Moczydlowski et a l . , 1988).
Here potassium channels in hippocampus are categorized as 
voltage-sensitive (gated) calcium-independent potassium 
channels, calcium-sensitive (dependent) potassium channels, 
receptor coupled (opening) potassium channels and 
miscellaneous potassium channels.
A. VOLTAGE-SENSITIVE CALCIUM-INDEPENDENT POTASSIUM CHANNELS
Voltage-gated potassium channels terminate the action 
potential, repolarize the neuron, set its resting 
potential, and regulate neurotransmitter release from the 
presynaptic terminal (Rehm & Tempel, 1991). This group can
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I
be divided at leastintofour types: delayed rectifier, slow 
delayed rectifier, A-channel and inward rectifier potassium 
channel.
The first potassium channel which was described is the 
delayed rectifier potassium channel (Ky), that activates 
rapidly on depolarization and inactivates slowly. This is 
the classic potassium conductance of Hodgkin and Huxley 
that is responsible for the repolarization phase of the 
action potential (Halliwell, 1990; Faingold , 1992). This
current is blocked by tetraethylammonium (TEA), (partly by 
5mM, completely by 25-30 mM) and is little affected by 
0.01-5 mM 4-aminopyridine. Modulation by transmitter 
substances has not been reported for Ky (Rutecki et al., 
1990; Storm, 1990) .
The fast transient potassium channel (KA) is activated 
much more rapidly upon depolarization than the delayed 
rectifier and is also inactivated faster than Ky (Rogawski, 
1985; Halliwell, 1990). KA is involved in spike
repolarization and reduces the interspike interval to space 
successive action potentials (Hille, 1984). This current is 
blocked by 1-5 mM 4-aminopyridine (4-AP) and dendrotoxin, 
a toxin from snake venom, (DTX, 50-300 nM) in the 
hippocampus (Storm, 1990).
Kd or the slowly inactivating potassium channel was 
recently shown in rat hippocampal slices (Storm, 1988). In
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contrast to KA, this channel is much more sensitive to 4- 
aminopyridine (30 nM) . It activates at potentials that are 
more negative than the spike threshold and inactivates very 
slowly. Kp can cause a several seconds long delay in the 
onset of firing in response to long-lasting depolarizing 
stimuli. KD seems fast enough to participate in spike 
repolarization and the presynaptic spike broadening due to 
block of KD may mediate the increase in transmitter release 
which is seen with small doses of 4-AP (Storm, 1988, 1990).
Inward rectifier potassium channels are activated by 
hyperpolarization, rather than depolarization, and they can 
pass larger K+ currents into the cell than outwards. Because 
of this behaviour, which is opposite to the classical 
delayed rectifier currents, this type of channel is often 
known as the "anomalous rectifier” (Harvey, 1993).
B . CALCIUM-DEPENDENT POTASS IUM-CURRENTS
The existence of calcium mediated increases in 
potassium-conductance was shown in both CA1 and CA3 regions 
of guinea-pig (Schwartzkroin and Stafstorm, 1980) and rat 
hippocampus (Alger and Nicoll, 1980). Calcium-dependent 
(activated) potassium channels KCa which are common in
excitable and secretory cells, are dependent on the free
2+intracellular Ca concentration which may or may not be 
voltage-gated. An increase in the intracellular calcium 
leads to an increase in the opening of these channels
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(Faingold, 1992). These channels have been categorized into 
at least three subdivision as a big (high) conductance 
calcium-activated potassium channel or fast calcium- 
activated potassium channel (BK^), medium (intermediate) 
conductance calcium-activated potassium channel (IKCa) and 
slow (small) conductance calcium-activated potassium 
channel, SKCa (Blatz and Magleby, 1987; Storm, 1988; 
Halliwell, 1990).
The BKCa repolarizes the action potential and the SKCa 
reduces action potential discharge rate (accommodation or 
adaptation) that typically occurs during a long duration 
depolarization (Nicoll, 1988). The BKCa channel is very 
voltage-dependent and is blocked by charybdotoxin and 
TEA(Goh et al., 1992; Goldstein & Miller, 1993). The SKCa 
channel has little or no voltage-dependency but higher than 
BKCa is calcium dependent and is resistant to TEA (Lancaster 
& Adams, 1986; Rudy, 1988). Apamin can block SKCa in
different tissues such as neocortex (Szente et al., 1988), 
neuroblastoma and rat muscle cell (Lazdunski et al . , 1985), 
sympathetic neurones (Kawai and Watanabe, 1986) and 
ganglion cells (Nishimura et a l . , 1988; Goh and
Pennefether, 1987). The slow AHP is also decreased or 
abolished by acetylcholine, histamine, serotonin,
noradrenaline (Nicoll, 1988; McCormick & Williamson, 1989; 
Bijak et al., 1991) Adenosine at less than 50 pM
potentiated the slow AHP in rat hippocampus slices (Greene 
and Haas, 1985).
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C. RECEPTOR-OPERATED POTASSIUM CURRENTS
Several neurotransmitters modify neuronal excitability 
by modulating the function of K+ channels. Potassium channel 
regulation by these neurotransmitters differs from the 
action of neurotransmitters such as acetylcholine on 
nicotinic receptors. Here the channel is a separate 
molecule from the receptor and the effects on potassium 
channels are mediated via second messengers activated as a 
result of neurotransmitter-receptor interaction (Rudy, 
1988). There are at least three receptor-coupled channels: 
M-current, atrial muscarinic-activated potassium channel 
(Kach) anc* 5-HT-inactivated channel (k5-{jt) • Here the M- 
current, which is more important in neurones will be 
explained.
The M-current (Ky) was so called because, in the 
original tests on frog ganglion cells, it was inhibited by 
muscarinic acetylcholine receptor agonists, such as the 
alkaloid muscarine (Brown, 1988). The M-current is a slow, 
"non-inactivating" voltage-dependent potassium current and 
activates close to rest or at hyperpolarized potentials 
(Rudy, 1988). In hippocampal pyramidal cells, Ky underlies 
an early phase of spike frequency adaptation, and it seems 
to be the main factor in the medium AHP which follows a 
single spike or spike burst (Storm, 1990). Besides 
acetylcholine, Ky may be modulated or blocked by serotonin 
(McCormick & Williamson, 1989), 1 mM Ba2+, or 5-10 mM TEA,
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but not by 0.1-lmM 4-AP. Somatostatin, on the other hand, 
seems to enhance Ky in rat CA1 cells (Brown, 1988; Storm , 
1990) .
D. MISCELLANEOUS POTASSIUM CHANNELS
There are some other potassium channels such as ATP- 
sensitive potassium channels (KATp) , sodium-activated 
potassium channels (KNa) and cell-volume-sensitive potassium 
channels (Ky0l) w^ich could not completely be categorized in 
the above classification.
ATP-sensitive potassium channels constitute a new 
class of potassium channels that link membrane potential 
variations to the bioenergetic situation of the cell. An 
increase of internal concentration of ATP tends to close 
this channel and produce a depolarization (Bernardi & 
Lazdunski, 1993). In pancreatic cells, where channel
function is relatively well understood, depolarization
induced by elevated ATP levels subsequent to glucose
2+metabolism opens voltage-gated Ca channels to release 
insulin. Sulfonylurea compounds such as glibenclamide can 
block this potassium channel and trigger insulin release 
(Gopalakrishnan et al . , 1993). The existence of
sulfonylurea binding sites associated with ATP-sensitive K+ 
channels have been shown in the hippocampus and other parts 
of brain (Mourre et al., 1989, 1991; Ohno-Shosaku &
Yamamoto, 1992). Hypoglycaemia or hypoxia in CNS can
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activate KATp as a neuroprotect ive mechanism of neuronal 
cells. For example during anoxia, when cellular levels of 
ATP decline, these channels are activated and block 
glutamate release (Miller, 1990; Tromba et al., 1992, Zini 
et al., 1993) .
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14. HIPPOCAMPAL SLICES
The in vitro slice model has been widely used over the 
past several years. In vitro brain slices have considerable 
value as pharmacological tools with which to study the 
physiological actions of neurotransmitters and drugs on the 
central nervous system. Several aspects of the slice 
preparation facilitate this type of analysis (Dunwiddie et 
al . , 1983). The lamellar structure of hippocampus
(Andersen, 1971), with its rather simple three-layered 
cortex, well-defined input and output pathways 
(Schwartzkroin,1987) and its suitability for evoking large 
extracellular potentials (Dunwiddie et al. , 1983) makes it 
a natural choice for a slice preparation.
A. ANATOMY OF HIPPOCAMPUS
In the brains of mammals the hippocampus is a 
bilaterally represented structure that appears as a ridge 
extending into the lateral ventricle. The outer surface of 
the hippocampus is composed of myelinated fibres arising, 
in part, from cells of the hippocampus, most of which leave 
the region through a large efferent pathway, the fornix. 
The outer covering is called the alveus, and fibres in it 
give rise to the fimbria that, in turn, is continuous with 
the fornix (Isaacson,1987).
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B. INTERNAL STRUCTURE
The hippocampal formation can be divided into the
Ammon’s horn, the dentate gyrus, and subiculum. Based on 
the Golgi preparations, the anatomist Lorente de No divided 
Ammon’s horn into four subfields: CA (Cornu Ammonis) 1 to 
CA4. More recent evidence strongly supports the view that 
the CA4 zone belongs to the dentate gyrus (Witter, 1989). 
From the outer layer to more medial, Ammon’s horn contains 
alveus, and strata oriens, pyramidale, radiatum, lacunosum 
and the molecular layer. The dentate gyrus consists of 
closely packed cells which are called granule cells. These 
cells have dendritic brushes that extend only in one 
direction: toward the outer , molecular layer of the gyrus 
(Isaacson, 1987). The distal part of CA1 borders the
subiculum which is distally replaced by the pre- and para 
subiculum, and the adjacent entorhinal cortex ventrally and 
retrosplenial cortex dorsally (Witter, 1989; Isaacson,
1987).
C. INTRINSIC CONNECTIVITY OF HIPPOCAMPUS
Neuronal input reaches the hippocampus from entorhinal 
regions, which sends a digest or summary of what is 
occurring in the neocortex and consequently, the
environment, to the hippocampal formation. The entorhinal 
cortex via the perforant pathway has a massive projection 
predominantly in the dentate gyrus. Projections to Ammon’s
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horn also have been described (Witter 1989). The granule 
cells of the dentate gyrus project through their mossy 
fibres to CA3. Pyramidal cells in CA3 give rise to 
collateralized axons of which the so-called Schaffer- 
collaterals provide the major input to CA1. From cells in 
the CA3 area axons leave the hippocampus via the fimbria 
and fornix, largely terminating in the lateral septal area. 
In general, the Schaffer collaterals synapse in the stratum 
radiatum and stratum oriens with the dendrites of CA1 
pyramidal cells. Finally, neuronal ontput from the CA1 
cells exit into the alveus and subsequently into the 
fornix, also projecting in large part to the septal area 
and the subicular region (Skrede & Westgaard, 1971; 
Isaacson, 1987).
D. FUNCTION OF HIPPOCAMPUS
Since the late 1950s, it has been popular to associate 
the hippocampus with some form of memory. This is due in 
large part to the recent memory deficiencies of Dr. 
Williams Scoville’s patient, H.M., who demonstrated such 
impairment after bilateral removal of the hippocampal 
formation and its associated medial temporal lobe 
structures (Isaacson, 1987). This patient had a profound 
impairment in new learning, but he had intact access to 
representations of remote memory (Eichenbaum et al., 1992). 
Long-term potentiation which is believed to have a role in 
memory can be efficiently induced in hippocampus. Using
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specific gene deletions that eliminate hippocampal LTP, 
impairment of hippocampal-dependent learning was 
demonstrated (Eichenbaum & Otto, 1993).
15. ADVANTAGES AND DISADVANTAGES OF BRAIN SLICES
In vitro slice models, like hippocampal slices, have 
advantages versus in vivo models:
-Technical simplicity and multiplicity: recordings can be 
obtained using extracellular, intracellular and whole-cell 
patch-clamp techniques (Henderson, 1992);
-Stability of model: There is no pulsation or respiration 
which may interfere with recording;
-No systemic metabolism and biotransformat ion. This is a 
good point for a new chemical agent to be closely examined; 
-Improved visualization of tissue;
-Easy changing of extracellular fluid.(Clark and Wilson, 
1992; Schwartzkroin 1981,1987).
Brain slices, like all preparations, have 
disadvantages and limitations as follows:
-Loss of inputs: Some afferents such as noradrenaline,
serotonin and acetylcholine cannot be activated in 
hippocampal slices in vitro (Dunwiddie et a l ., 1983); 
-Trauma and anoxic period of dissection;
-Limitation of tissue life-acute nature of the preparation 
(Schwartzkroin 1981,1987; Clark and Wilson, 1992).
METHODS
AND
MATERIALS
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2. METHODS AND MATERIALS
A. PREPARATION OF SLICES
Male Wistar rats (170-210 g) were anaesthetized with 
urethane (1.3 g/kg, I.P.) and decapitated using a 
guillotine. The scalps were removed and brains were rapidly- 
taken out and put in ice-cold and oxygenated artificial 
cerebrospinal fluid (ACSF). The cerebellum was removed and 
the two cerebral hemispheres were separated with a surgical 
blade. The hippocampi were carefully pulled out with 
spatulas and put on the filter paper and cut transversely 
into 450 pm thick slices using a Mcllwain tissue chopper. 
The slices were then transferred onto another filter paper 
in a petri dish containing ice-cold oxygenated ACSF and 
separated with glass seekers. The petri dish, with slices, 
was put into the incubation chamber containing an ACSF- 
saturated atmosphere of 95% 02 and 5% C02 at room temperature 
for at least one hour before using. The fluid in the petri 
dish was adjusted to just cover the slices.
B. BATHING MEDIUM
The formula of the bathing medium, artificial 
cerebrospinal fluid (ACSF), was as follows: (mM): NaCl 115, 
KH2P04 2.2, MgSO^ 1.2, CaCl2 2.5, NaHCO^ 25 and glucose 10.
In some antidromic experiments, calcium was omitted 
(calcium-free medium) or reduced to 0.1-0.24 mM (low calcium
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medium). A n a l y s i s  of the n o m i n a l l y  c a l c i u m - f r e e  sol u t i o n  by
flame i o n i sation s p e c t r o s c o p y  r e v e a l e d  a residual level of
12 uM calcium.
In some antidromic experiments, calcium was omitted and 
MgSO^ was raised from 1 .2 to 2 or 4 mM (calcium-free high 
magnesium).
In high potassium experiments, potassium was raised to 
8.5 mM and sodium chloride was reduced accordingly.
C. BATH SUPERFUSION AND APPLICATION OF DRUGS
Individual slices were transferred using a brush to a 
one ml capacity recording chamber and superfused with ACSF 
at 30°C ± 0.5, gassed with the O2/CO2 mixture to yield a pH 
of 7.4. The slices were kept submerged in medium with a 
metal holder and the medium was perfused continuously from 
a gravity feed or a pump at a rate of 4 ml/min.
In some experiments adenosine was applied locally to 
the somatic or dendritic region of pyramidal cells using 
pressure ejection from glass micropipettes (8-10 piM tip 
diameter), containing a solution of 20 nM adenosine in ACSF 
for orthodromic stimulation or 10 mM in calcium-free or low 
calcium media for antidromic stimulation. In this set of 
experiments an attempt was made to maintain the fluid layer 
covering the slice as thin as possible.
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D. RECORDING ELECTRODS
The electrodes for recording were made from 
borosilicate glass tubing containing a glass capillary fibre 
for easy filling. The tubing with characteristic of 1 mm 
internal diameter and 2 mm external (GC 200 F) was purchased 
from Clark Electromedical Instruments, U.K.. With a Kopf 
vertical electrode puller the electrodes were pulled and 
separated to yield two sharp tip electrodes. Under 
microscopic vision, the tips of the electrodes were broken 
with a glass probe to provide a tip diameter 2-4 pm. The 
electrodes were filled with 2 M sodium chloride via a 
syringe bearing a 0.2 pm syringe filter.
E. RECORDING AND STIMULATION
After orthodromic stimulation of Schaffer collateral 
fibres in stratum radiatum near the border of CA2-CA3, 
recordings were made in the CA1 pyramidal cell layer or the 
stratum radiatum for population spikes or field EPSPs 
(fEPSPs) respectively. Stimulation of the alveus was used to 
induce antidromic invasion of CA1 cells by a bipolar 
electrode (figure 2.1.). Pulses of 0.1 ms duration and 100- 
500 pA amplitude were delivered every one minute. For 
orthodromic fEPSPs the duration of stimulus was decreased to 
20-50 ps. Recordings were made with 2-4 pm diameter glass 
microelectrodes containing 2 M NaCl. The recorded signals 
were amplified by a Neurolog amplifier and displayed on a
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Figure 2.1. Anatomy of the hippocampal formation and the 
placement of the electrodes. (A). The hippocampal formation 
is enlarged to show the main neuronal elements of 
structure. (B). Lateral view of the rat brain with parietal 
and temporal neocortex to expose the hippocampal formation. 
After orthodromic stimulation of Schaffer collateral fibres 
in stratum radiatum near the border of C A 2 - C A 3 , recordings 
were made in the CA1 pyramidal cell layer or the stratum 
radiatum for population spikes (P.S.) or field EPSPs 
(fEPSPs) respectively. Stimulation of the alveus was used 
to induce antidromic invasion of CA1 cells as shown in (A). 
Abbreviation for figure: alv.= alveus; D . G= dentate gyrus; 
ento.= entorhinal area; fim.= fimbria; mf.= mossy fibres; 
p p .= perforant path; sch.= Schaffer-co11 a t e r a 1s ; mm= 
millimetre. (Revised from Andersen et a l ., 1971)
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Gould storage oscilloscope and then plotted on a 
thermosensitive chart recorder. Spontaneous activity was 
recorded on a Grass polygraph (model 79 D ) .
The orthodromic population spikes (P.S.), fEPSPs and 
also secondary spikes (S.S.) after antidromic stimulation 
were reduced to 75% to avoid supramaximal stimulation.
F. ANALYSIS OF DRUG EFFECTS
The size of the population spike following orthodromic 
stimulation and the first antidromic spike and secondary 
spike were measured as the peak to peak amplitude. The size 
of fEPSPs was measured between the negative going peak and 
the base line of stimulation (figure 2.2.).
The number of bursts of spontaneous activity was 
counted for 10 minutes and reported as the burst frequency 
per minute.
Results were considered as percentage of change of the 
spike size by drug compared with control size. The size of 
evoked potential in the absence of any agents is considerd 
as zero percent change in potential size.
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Population Spikes
1 mv
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Antidromic Stimulation
Convulsant Agents or Media 2 mv
10 ms
Figure 2.2. Demonstration and measurement of orthodromic 
and antidromic potentials evoked in the CA1 region.
Antidromic potentials are demonstrated in (A) normal ACSF 
and in (B) the presence of convulsant agents or media.
Explanations of each part of the evoked potentials are as
follows:
1) Stimulus artifact;
2) Presynaptic fiber volley potential that reflects the 
compound action potential travelling in the stratum
radiatum towards CA1;
3) The population excitatory postsynaptic potential or 
population EPSP is a slow positive going potential which 
reflects the depolarization of dendrites by the 
synaptically released transmitter;
4) The population spike is a negative going spike-like 
potential which reflects the production of the action 
potentials by the pyramidal neurones once the EPSP has 
depolarized the cells to threshold;
5) The first antidromic spikes which reflect the compound 
action potential from axon to soma;
6) Secondary spikes that reflect firing of cell bodies;
7) Amplitude of population spikes, fEPSPs or secondary 
spikes.
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G. STATISTICAL ANALYSIS
Results are presented as mean % ± s.e.m (standard error 
of the mean) for n experiments, and the statistical 
significance of any difference assessed by a paired or 
unpaired Student’s t-test. For multiple comparisons an 
analysis of variance (one-way), ANOVA, with post test of 
Tukey-Kramer were used. Differences were considered 
significant with P<0.05 or as otherwise mentioned.
H. CHEMICAL AGENTS
Constituents of ACSF were of Analar grade and purchased 
from BDH Chemicals Ltd. UK. Chemical agents generally were 
purchased from Sigma Chemical Co, UK, except for N6- 
cyclopentyladenosine (CPA) which was purchased from Research 
Biochemicals Inc. (Semat Industries, UK) and levcromakalim 
(BRL 38227) which was provided from SmithKline Beecham 
pharmaceuticals. PD81723 was a gift from Parke-Davis.
Dimethyl sulfoxide (DMSO) was used as the vehicle for 
carbamazepine, CPA, levcromakalim, PD81723, (R-)-N^-
phenylisopropyladenosine (R-PIA), thapsigargin and 
tolbutamide. Control experiments showed that DMSO itself had 
no effect on the slice at concentrations up to 0.1%.
8-cyclopentylthyeophyl1ine (CPT) and theophylline were 
iissolved in sodium hydroxide (1 M ) . The buffering capacity of the
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ACSF ensured that the final pH of the perfusing medium was 
restored to pH 7.4.
Adenosine deaminase (ADA) from calf intestinal mucosa, 
type VII, lyophilized powder was used.
In other cases the vehicle was the superfusing medium 
such as ACSF or ACSF without calcium.
RESULTS
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3. RESULTS
UJiCTiOiJ Ij COMPARISON 01* ADENOSINE ACTIONS ON OimiOUiiOMiC 
AiLL) ANTIJUROMI C EJSS-PONCIiS 01* CAI NEURONES
3.1. EFFECT OF CALCIUM ON ADENOSINE INHIBITORY ACTIONS
3.1.1. EFFECT OF ADENOSINE ON ORTHODROMIC POPULATION SPIKES
In normal ACSF (2.5 mM calcium), adenosine 
concentrat ion-dependently abolished or reduced the amplitude 
of the population spike (P.S.) of orthodromic CAI field 
potentials. A cumulative concentration-response curve for 
this effect is shown in figure 3.1. The depressant effect of 
adenosine was readily reversible and washed out in about 5 
minutes (figure 3.2.).
The threshold concentration for adenosine was 1 pM and 
20 pM abolished the population spikes. Tachyphylaxis or 
refractoriness was not seen with repeated treatment of 
adenosine. Adenosine had no effect on the presynaptic fiber 
volley.
The population spikes evoked by orthodromic stimulation 
were completely abolished by changing from normal ACSF to 
nominally calcium-free or low calcium (0.24 mM) medium. This 
process took about 10 minutes. The presynaptic volley did 
not change in calcium-free or low calcium medium (n=3).
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Figure 3.1. Cumulative concentration-response curve for 
the depression of orthodromically evoked CAI population 
spikes (P.S.) by adenosine. Each point represents the mean 
± s.e.m. for n=6 experiments. A paired t test was employed 
to determine the significance level( =P<0.05; =P<0.01;
m =P<0.001) .
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3.1.2. EFFECT OF CALCIUM-FREE MEDIUM ON ANTIDROMIC POTENTIAL
In nominally calcium-free medium, bursts of multiple 
population spikes (secondary spikes) were obtained in 
response to antidromic stimulation. These became apparent 3- 
10 minutes after beginning calcium-free perfusion, with 
stable, maximum amplitude spikes being obtained in less than 
30 minutes. These stable bursts usually consisted of 2-3 
afterdischarges (see figure 3.6.).
The effect of calcium-free medium on slices was 
reversible and with reinfusion of normal ACSF medium, 
antidromically-induced responses fully recovered and 
epileptiform discharges disappeared in about 5 minutes. 
Reperfusion of the slice with calcium-free medium then 
quickly induced bursts and stable bursts appeared in less 
than 10-15 minutes. This shorthening of burst development 
latency was also seen in slices superfused with high 
potassium (8.5 mM in normal ACSF) and washed out for 10 
minutes.
In order to ensure testing in the absence of synaptic 
transmission, drugs were applied to the medium after 45 
minutes perfusion with calcium-free medium.
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3.1.3. E F F E C T  OF A D E N O S I N E  O N  A N T I D R O M I C  B U R S T S  I N D U C E D  IN
C A L C I U M - F R E E  M E D I U M
In nominally calcium-free medium, a wide range of 
adenosine concentration, 0.020-5 mM, was used. Adenosine was 
perfused for 10 minutes and for each slice only one 
concentration of adenosine was used to prevent any 
desensitization.
In contrast to the very sensitive effect of adenosine 
in reducing orthodromic population spike size in normal 
ACSF, adenosine was almost ineffective in suppression of 
epileptiform burst discharges, sensitivity almost being 
abolished in calcium-free media except for varible and small 
responses at high concentrations (figure 3.3.). Adenosine 
had no significant effect on the first antidromic spike 
ampli tude.
To find the reason for the loss of adenosine 
postsynaptic sensitivity in calcium-free medium different 
posssibi1ities were considered such as:
1) Decrease of receptor binding of adenosine,
2) Increase of metabolism and uptake of adenosine,
3) Increase of overall excitability,
4) Loss of ioni c conductances,
5) Interact ion between A2 and Aj receptors
6) Desensitization to adenosine
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Figure 3.3. Concentration-response curve for the
depression of antidromically evoked CAI secondary spikes
(S.S) by adenosine in calcium free medium. Each point
represents the mean ± s.e.m. for n as mentioned in the
parenthesis. A paired Student’s t test was employed to
i titdetermine the significance level ( =P<0.05; =P<0.001).
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3.1.4. E F F E C T  OF A D E N O S I N E  O N  A N T I D R O M I C  B U R S T S  I N D U C E D  IN
L O W  C A L C I U M  M E D I U M  (0.24 mM)
In low calcium medium (0.24 mM) , a secondary spike 
developed in response to the antidromic stimulus within 5-15 
minutes. The stable burst took more than 30 minutes to 
develop in some slices. In low calcium more secondary spikes 
(3-6) apeared than in calcium-free medium.
Changing a calcium-free medium to a low calcium medium 
initially caused a decrease of secondary spike size but 
after about 20 minutes the amplitude returned to that in 
calcium-free medium (n=3). The effect of low calcium on the 
slices was reversible and following reinfusion of normal 
calcium medium, antidromically elicited responses recovered 
fully.
Raising the concentration of calcium to 0.24 mM also 
increased the sensitivity to adenosine concentration- 
dependently (figure 3.4.). For example, adenosine at 100 pM 
reduced the secondary spike size by 55.02 ± 3.17% (n=6,
P<0.001) .
Because of desensitization to adenosine in low calcium 
media, each concentration of adenosine was tested on only 
one slice. This phenomenon will be explained more in section 
3.1.6.
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Figure 3.4. Concentration-response curve for the effect of 
adenosine on antidromically induced secondary spike (S.S.) 
size in low calcium media (0.24 mM). Each point represents 
the mean ± s.e.m. for n>3 . A paired t test was employed to 
determine the significance level (*=P<0.05; ** = P<0.01;
*** = P<0.001) .
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3.1.5. E F F E C T  OF A D E N O S I N E  ON  A N T I D R O M I C  B U R S T S  INDUCED IN
C A L C I U M - F R E E  M E D I U M  W I T H  A D D E D  M A G N E S I U M  (0.8 O R  2.8 mM)
As in calcium-free and low calcium solutions, bursts of 
action potentials appeared in calcium-free media in the 
presence of added 0.8 or 2.8 mM magnesium (total of 2 and 4 
mM respectively), although in this medium more time was 
needed to reveal the first secondary spike. In calcium-free 
medium plus 4 mM magnesium in some slices it took 60 minutes 
for the first secondary spike to appear and more than 90-120 
minutes for stable bursts to develop.
After switching from calcium-free medium to the medium 
with total 2 mM magnesium the first secondary spike size 
decreased (n=4), although after 20-30 minutes no significant 
difference between amplitude in the two media was seen. In
two slices the secondary spikes even increased in size
(30.77% and 17.65%).
Adding 2.8 mM magnesium to calcium-free medium in which 
antidromic bursts were established compeletely abolished 
secondary spikes at first, but after about 45 minutes more 
a secondary spike appeared again.
Raising the magnesium concentration by 0.8 mM increased
the inhibitory effect of adenosine after 10 minutes
superfusion (figure 3.5.). For example, adenosine at 200 nM 
reduced the secondary spike size by 90.42 ± 5.42% (P<0.01, 
n=4, figures 3.5. and 3.6. ).
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Figure 3.5. Concentration-response curve for the effect of 
adenosine on antidromically induced secondary spike (S.S.) 
size in calcium-free media plus 0.8 mM magnesium (total of 
2 mM magnesium). Each point represents the mean ± s.e.m. 
for n>3. A paired t test was employed to determine the 
significance level (**=P<0.01).
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Adenosine concentrat ion-dependently and effectively 
decreased or abolished secondary spikes in calcium-free high 
magnesium (4mM) (figure 3.7.)* Adenosine at a concentration 
of 20 pM, (the same concentration that abolished the 
orthodromic population spikes in normal ACSF) completely 
abolished the antidromic bursts in calcium-free medium high 
magnesium (4 mM magnesium).
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Figure 3.7. Cumulative concentration-response curve for the 
effect of adenosine on antidromically induced secondary 
spikes (S.S.) in calcium-free media containing 4 mM 
magnesium. Each point represents the mean ± s.e.m. for n=8. 
A paired t test was employed to determine the significance 
level (**=P<0 .01; m =P<0 . 001) .
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3.1.6. D E S E N S I T I Z A T I O N  T O  A D E N O S I N E  IN L O W  C A L C I U M  M E D I U M
Raising the divalent cation concentrations in calcium- 
free medium increased adenosine postsynaptic sensitivity as 
just described. This was accompanied by desensitization to 
adenosine (figure 3.8.).
Desensitization was normally apparent after the 
previous exposure of slices to several application of 
adenosine, although exposure to low concentrations was 
sufficient to enable subsequent desensitization to higher 
concentrations. For example exposure of naive slices to 100 
pM adenosine caused inhibition of secondary antidromic 
spikes by 55.02 ± 3.17% (n=6) after 10 min. If slices were 
previously exposed for periods of 10 minutes to 20 pM and 50 
pM adenosine with washing between each period to regain 
control response size, then the inhibition by 100 pM 
adenosine was reduced to 34.9 ± 1.63% (P<0.001, n=4).
Similarly, responses to 2 mM adenosine were reduced from 
92.19 ± 3.62% in naive slices to 33.75 ± 2.30% following 
pretreatment with lower concentrations of adenosine (P<0.01, 
n=3) .
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3.1.7. E F F E C T  OF S O M A T I C  O R  D E N D R I T I C  A P P L I C A T I O N  OF
A D E N O S I N E  O N  A N T I D R O M I C  BURSTS INDUCED IN C A L C I U M - F R E E  O R
L O W  C A L C I U M  M E D I U M
To assess whether desensitization to adenosine was 
occurring at the somatic or dendritic sites, adenosine was 
applied locally in these regions.
When applied locally from micropipettes containing 10 
mM adenosine, the purine __ was not able to depress 
antidromically induced bursts in calcium-free medium, 
whether applied into the somatic or dendritic regions. 
However, in low calcium media adenosine did decrease the 
secondary spikes when applied either to the cell bodies or 
dendrites (figure 3.9.). The effect of adenosine was 
desensitized after second and third applications to the 
dendritic site (table 3.1.).
Table 3.1. Effect of somatic or dendritic adenosine on 
antidromic secondary spikes in low calcium media.
Somat ic Dendri t ic
First application 30.60 ± 5.27% 40.22 ± 7.03 %
Second application 32.35 ± 4.79 24.52 ± 7.58
Third application 30.27 ± 5.25 20.50 ± 9.11
n= (6) (6)
Significantly different from first application, P<0.05,
ANOVA and Tuky-Kramer post test.
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Figure 3.9. Histogram showing the effect of somatic or 
dendritic local microinjection of adenosine on orthodromic 
population spikes in normal ACSF or antidromic secondary 
spikes in calcium-free or low calcium (0.24 mM) medium. 
Each vertical bar represents the mean ± s.e.m. for n>3. A 
paired t test was employed to determine the significance
**
level( =P<0.01).
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3.1.8. EFFECT OF SOMATIC OR DENDRITIC APPLICATION OF 
ADENOSINE ON ORTHODROMIC POPULATION SPIKES
In normal ACSF, when applied locally, adenosine was 
effective in reducing orthodromic potentials either at the 
soma region, 70.6% ± 16.4 inhibition (P<0.01, n=3) or in the 
dendritic tree, 58.2% ± 10.1 (P<0.01, n=5, figure 3.9.). For 
these effects the concentration of adenosine in the 
microinjection pipette was reduced to 20 pM.
3.1.9. PROLONGED SUPERFUSION OF ADENOSINE IN NORMAL ACSF
After perfusion of adenosine 10 pM for 10 minutes the 
orthodromic population spikes wre reduced by 39.71% ± 5.62 
(n=4, PcO.Ol). No sign of desensitization was seen after 
superfusing adenosine for 60 minutes in normal ACSF (figure
3.10.).
At high concentration, adenosine (2 mM) completely 
abolished orthodromic population spikes without any 
significant effect on the presynaptic volley (n=3). After 60 
minutes there was no sign of recovery of population spikes. 
Washout of the high concentration of adenosine took more 
than 30 minutes in order to restore the field potential.
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Figure 3.10. Prolonged effect of adenosine 10 pM on 
orthodromic population spikes (P.S.). Responses to 
adenosine did not desensitize during 60 minutes superfusion 
in normal ACSF. Each point represents the mean ± s.e.m. for 
n=4. A one-way analysis of variance (ANOVA) with post 
Tukey-Kramer multiple comparisons test was employed to 
determine the significance level (*=P<0.05; **=P<0.01;
m  = P<0.001) .
74
3.1.10. EFFECT OF PD81723, AN ALLOSTERIC ADENOSINE BINDING 
ENHANCER, ON THE INHIBITORY EFFECT OF ADENOSINE ON 
ORTHODROMIC POPULATION SPIKES
Bath application of PD81723 10 and 30 pM for 30 minutes 
alone had no significant effect on orthodromic population 
spikes in separate slices. At a concentration of 30 pM, 
PD81723 significantly increased the inhibitory effect of 
adenosine 5 pM (figure 3.11.).
3.1.11. INTERACTION OF PD81723 AND ADENOSINE ON ANTIDROMIC 
BURSTS INDUCED IN CALCIUM-FREE MEDIUM
In calcium-free media PD81723 10 and 30 pM had no
significant effect on burst activity in separate slices. 
This agent also did not enhance activity of adenosine 100 pM 
in calcium-free media (figure 3.12.).
75
A
CD
N
• r— (m
0)Cflc0
CDuO0
Q
50
40
30
20
10
0
I | Adenosine (AD) 5 jjM  
KXl PD 81723 10 
KXI PD 81723 10 jjM. + AD 5 yuM 
n.s.________
T
B
Adenosine 5 j jM
f\\l PD 81723 30 yuM 
50 KXI PD 81723 30 ytzM + AD
0N
* r— Hm
co
p2
0m
co
0?-!o
0
Q
40
30
20
10
0
** *
Figure 3.11. Histograms showing interaction of adenosine 
and PD81723 A) 10 |j.M B)30 jiM on orthodromically evoked CA1 
population spikes in normal ACSF. Each vertical bar 
represents the mean ± s.e.m. for n=8 and 5 for graphs A and 
B respectively. A paired t test was employed to determine
the significance level (*=P<0.05; **=P<0.01; m =P<0 . 001) .
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Figure 3.12. Histograms showing interaction of adenosine 
and PD81723 A) 10 pM B)30 pM on ant idromical ly evoked CA1 
secondary spikes in calcium-free medium. Each vertical bar 
represents the mean ± s.e.m. for n=3 and 5 for graphs A and 
B respectively. A paired t test was employed to determine 
the significance level. n .s .=non-significant.
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3.1.12. ROLE OF HYPEREXCITABILITY IN CALCIUM FREE-MEDIUM ON 
THE LOSS OF ADENOSINE SENSITIVITY
Since the removal of calcium increased excitability of 
cells and induced epileptiform activity, then one 
possibility to be considered was that adenosine lost its 
efficacy as a result of the overall increase in 
excitability. To test this the following experiments were 
done to decrease the excitability:
1) Decrease of evoked secondary spike size more than fifty 
percent,
2) Study of the postsynaptic effect of adenosine in another 
model of in vitro bursting,
3) Decrease the excitability using baclofen,
4) Using isolated CA1 to prevent any spontaneous activity.
3.1.12.1. EFFECT OF STIMULUS STRENGTH ON THE LOSS OF 
ADENOSINE SENSITIVITY IN CALCIUM-FREE MEDIUM
In calcium-free medium, adenosine 200 pM still had no 
significant effect even when stimulus strength was reduced 
so that the amplitude of the control secondary spike was 
less than 50% of its maximum (n=3). As mentioned in Methods, 
stimulus strength was reduced in all experiments to 
submaximal levels so as to yield a spike size of 
approximately 75% of maximum.
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3 . 1 . 1 2 . 2  E F F E C T  OF A D E N O S I N E  O N  A N T I D R O M I C  B U R S T S  INDUCED IN
H I G H  P O T A S S I U M  M E D I U M
With antidromic stimulation in the presence of high 
potassium (8.5 mM) and normal calcium media, the bursts 
began to develop within about 15 minutes and became stable 
after more than 30 minutes. Adenosine decreased the 
secondary spikes concentration-dependently and reversibly 
(f igure 3.13.).
In high potassium media, a release of excitatory amino 
acid occurs, and adenosine may suppress this kind of burst 
by reducing excitatory amino acid release presynaptically. 
For this reason kynurenic acid, an antagonist of excitatory 
amino acids, was used.
Kynurenic acid, 1 mM, abolished the antidromic 
secondary spikes in less than 3 minutes in the high 
potassium medium (n=3). Raising potassium levels to further 
induce bursts by direct depolarization of the cells was also 
unsuccessful. Kynurenic acid 1 mM still suppress the burst 
at higher concentration of potassium, 10 mM. At the 
concentration of 12 and 17 mM potassium alone or with 
kynurenic acid the first and secondary spikes abolished 
reversibly in about 2 minutes and did not recover for 30 
minutes superfusion of high potassium.
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Figure 3.13. Cumulative concentration-response curve for 
the depression of antidromically evoked CA1 secondary 
spikes (S.S.) by adenosine in high potassium (8.5 mM) 
medium. Each point represents the mean ± s.e.m. for n=3 
experiments except for adenosine 100 pM the mean for n=2. 
A paired t test was employed to determine the significance
level( =P<0.05).
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3.1.12.3 DEPOLARIZATION OF PYRAMIDAL CELLS BY VERATRIDINE
The use of veratridine, a sodium channel activator, for 
depolarization of pyramidal cells was also unsuccessful. In 
fact this agent time and concentration dependently abolished 
the first spikes. At 1 and 5 pM veratridine abolished the 
antidromic first spike in normal ACSF after about 30 and 15 
minutes respectively. Washout of veratridine took a long 
time but at 30 minutes partial recovery was seen.
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3.1.12.4. INHIBITORY EFFECT OF BACLOFEN
3.1.12.4.1. EFFECT OF BACLOFEN ON ORTHODROMIC POPULATION 
SPIKES
Baclofen concentration-dependently decreased the size 
of population spikes evoked in the CA1 area by orthodromic
stimulation (figure 3.14.). The maximum effect was seen at
5 (J.M which abolished the potential completely (n=3). The 
effects of this GABAg agonist were fully developed in less 10 
minutes and recovery from a single concentration on washout 
occurred in a similar time.
When a series of different concentrations of baclofen
was used on the same slice, full recovery from the 
depressant effect of baclofen took more than 15 minutes and 
in three slices about 30 minutes.
Baclofen, like adenosine, had no effect on the 
presynaptic fiber volley and no desensitization was seen 
with cumulative application of different baclofen 
concentrat ions.
The potency of baclofen on reduction of orthodromic 
potentials was much greater than adenosine. Comparing the 
effect of three concentrations of 1, 2, 5 pM these two
inhibitors were significantly different at the level of 
P<0.001 (n=6, unpaired Student’s t-test).
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Figure 3.14. Cumulative concentration-response curve for 
the depression of orthodromically evoked CA1 population 
spikes (P.S.) by baclofen. Each point represents the mean 
± s.e.m. for n=6 experiments. A paired t test was employed
♦ It
to determine the significance level( =P<0.05; =P<0.01;
m  = P<0.001) .
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3.1.12.4.2. EFFECT OF BACLOFEN IN CALCIUM-FREE MEDIUM
3.1.12.4.2.1. EFFECT OF BACLOFEN ON ANTIDROMIC INDUCED 
BURSTS IN CALCIUM-FREE MEDIUM
Unlike adenosine, which practically had no effect in 
calcium-free medium, baclofen continued to reduce secondary 
spike size in a concentration-dependent fashion even in 
calcium-free medium (figure 3.15.) although its potency was 
reduced. For example at 20 pM baclofen reduced the secondary 
spike amplitude by 48.48% ± 5.65 (P<0.001, n=21), although 
it had no effect on the first antidromic spike.
Because desensitization occured to baclofen in some 
slices, each concentration was tested on one one slice. The 
maximum effect of baclofen was seen with 500 pM. Washout of 
this concentration took more than 15 minutes.
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Figure 3.15. Concentration-response curve for the 
depression of antidromically evoked CA1 secondary spikes 
(S.S.) by baclofen in calcium free medium. Each point 
represents the mean ± s.e.m. for n>3. A paired Student’s t 
test was employed to determine the significance level 
(*=P<0 . 05 ; m =P<0.001) .
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3 . 1 . 1 2 . 4 . 2 . 2 .  I N T E R A C T I O N  OF A D E N O S I N E  A N D  B A C L O F E N  ON
A N T I D R O M I C  BURSTS INDUCED IN C A L C I U M - F R E E  M E D I U M
In order to study the role of overexcitability in 
calcium free-medium on the loss of adenosine postsynaptic 
sensitivity, combination of adenosine and baclofen was used. 
For each concentration of adenosine only one slice was used.
Adenosine alone at concentrations of 50, 100, 200 pM
had no effect on secondary spikes size. Even in the presence 
of baclofen, 20 pM, which decreasesthe secondary spike about 
50%, different concentrations of adenosine up to 200 pm did 
not decrease the antidromic potential size more than 
baclofen alone, in other words baclofen did not restore the 
inhibitory effect of adenosine (figure 3.16.).
In four experiments, responses to baclofen showed 
evidence of desensitization, and were excluded from the 
results.
After the presence of adenosine, 2 mM, for 10 minutes 
(which had no effect on secondary spikes) the addition of a 
just-maximal concentration of baclofen (500 pM) was still 
able to abolish the secondary evoked potential with no 
recovery during 30 minutes superfusion (n=4).
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Figure 3.16. Histogram showing effect of adenosine and 
baclofen on antidromically evoked CA1 secondary spikes 
(S.S.) in calcium-free medium. Each vertical bar represents 
the mean ± s.e.m. for n=4-10. A paired t test was employed 
to determine the significance level (*=P<0.05; **=P<0.01;
Hi
=P<0.001). n .s .=non-significant.
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3.1.12.5. EFFE C T  OF  A D E N O S I N E  O N  I S O LATED CA1 A N T I D R O M I C
B U R S T S  IN C A L C I U M - F R E E  M E D I A
Although in calcium-free media, no spontaneous 
"epileptiform” activity was noted, the possibility was 
considered that small amplitude spontaneous activity could 
have contributed to the loss of adenosine sensitivity in 
calcium-free media. Experiments were therefore performed in 
which the connection between CA1 and CA3 was cut using a 
surgical blade.
In these isolated CA1 slices, adenosine 200 uM still 
had no significant effect on secondary spikes size (n=4, 
2.79% ± 2.16, P=0.286, n.s.).
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3.1.13. INHIBITORY EFFECT OF KYNURENIC ACID
3.1.13.1. EFFECT OF KYNURENIC ACID ON ORTHODROMIC POPULATION 
SPIKES
In normal ACSF, kynurenic acid, which blocks excitatory 
amino acid receptors, reduced or abolished, concentration- 
dependently orthodromic population spikes evoked in CA1 
(figure 3.17.). Kynurenic acid was applied for 10 minutes. 
Onset of the effect and washout of^kynurenic acid took about 
5 minutes.
3.1.13.2. EFFECT OF KYNURENIC ACID ON ANTIDROMIC BURSTS 
INDUCED IN CALCIUM-FREE MEDIUM
Kynurenic acid at concentrations of 1 and 5 mM had no 
significant effect on first or secondary spike size in 
calcium-free or low calcium medium (figure 3.17.).
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Figure 3.17. Histogram showing the effect of kynurenic acid 
on orthodromically or antidromically evoked CA1 population 
spikes or secondary spikes (S.S.) respectively in normal 
ACSF or calcium-free media. Kynurenic acid failed to 
decrease S.S. size. Each vertical bar represents the mean 
± s.e.m. for n=6 and n=3 with orthodromic or antidromic 
stimulation respectively. A paired t test was employed to 
determine the significance level (**=P<0 .01; ***=P<0 . 001) .
St.=stimulation.
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3.1.14. ROLE OF M E T A B O L I S M  O R  U P T A K E  OF  A D E N O S I N E  IN
C A L C I U M - F R E E  M E D I U M  ON  TH E  LOS S  OF A D E N O S I N E  S E N S I T I V I T Y
3.1.14.1. INHIBITORY EFFECT OF 2-CHLOROADENOSINE
3.1.14.1.1. EFFECT OF 2-CHLOROADENOSINE ON ORTHODROMIC 
POPULATION SPIKES
In normal ACSF, the adenosine analogue, 2-
chloroadenosine effectivly decreased or abolished_ the 
population spike evoked in CA1 by orthodromic stimulation 
(figure 3.18.). 2-Chloroadenosine had no effect on the 
presynaptic volley. The analogue of adenosine was applied 
for 15 minutes.
Its action was not as quick as adenosine but it washed 
out in less than 10 minutes.
3.1.14.1.2. EFFECT OF 2-CHLOROADENOSINE ON ANTIDROMIC BURSTS 
INDUCED IN CALCIUM-FREE MEDIUM
Even at high concentration, 2-Chloroadenosine, which is 
not degradable or subject to uptake processes, had no 
significant effect on secondary spikes size evoked in CA1 
area in calcium-free medium. It also had no effect on the 
first antidromic spike (figure 3.18.).
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Figure 3.18. Histogram showing effect of 2-chloroadenosine 
(2C1ADO) on orthodromically or antidromically evoked CA1 
population spike or secondary spikes respectively in normal 
ACSF or calcium-free media. Each vertical bar represents 
the mean ± s.e.m. for n=5 and n=3 with orthodromic or 
antidromic stimulation respectively. A paired t test was 
employed to determine the significance level(**=P<0.01 ; 
***=P<0 . 001) . S t . =S t imulat ion.
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3 . 1 . 1 4 . 2 .  I N H I B I T O R Y  E F F E C T  OF ( R - ) - N 6- 
Phenylisopropyladenosine (R-PIA)
3.1.14.2.1. EFFECT OF R-PIA ON ORTHODROMIC POPULATION SPIKES
In normal ACSF, R-PIA decreased or abolished the 
orthodromic population spike evoked in CA1. It had no effect 
on the presynaptic volley. R-PIA was applied for 50 minutes 
for 10 nM and 30 minutes for 50 nM. The response onset and 
washout were slow and concentration dependent (figure 
3.19.). The full response to 10 and 50 nM of R-PIA appeared 
after about 45 and 15 minutes respectively.
3.1.14.2.2. EFFECT OF R-PIA ON ANTIDROMIC BURSTS INDUCED IN 
CALCIUM-FREE MEDIUM
In calcium-free media, R-PIA with high concentration 
had no significant effect on first or secondary antidromic 
spikes (figure 3.19.). R-PIA was applied 30 minutes.
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Figure 3.19. Histogram showing effect of (R-)-N- 
^Phenylisopropyladenosine(R-PIA) on orthodromically or 
antidromically evoked CA1 population spikes (P.S.) or 
secondary spikes (S.S.) respectively in normal ACSF or 
calcium-free media. Each vertical bar represents the mean 
± s.e.m. for n=5 and n=3 with orthodromic or antidromic 
stimulation respectively. A paired t test was employed to 
determine the significance level (**=P<0 . 01 ; m =P<0 . 001) .
St.=stimulation.
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3.1.14.3. EFFECT OF S-(2-HYDROXY-5-NITROBENZYL)-6- 
THIOINOSINE (HNBTI) ON ADENOSINE SENSITIVITY
3.1.14.3.1 EFFECT OF HNBTI ON ORTHODROMIC POPULATION SPIKES
Superfusion of HNBTI 100 pM alone for 30 minutes had no 
significant effect on orthodromic population spikes. 
Coadministration of HNBTI 100 pM potentiated the inhibitory 
effect of adenosine 5 pM (figure 3.20.).
3.1.14.3.2. EFFECT OF S-(2-HYDROXY-5-NITROBENZYL)-6- 
THIOINOSINE (HNBTI) ON ADENOSINE SENSITIVITY OF ANTIDROMIC 
BURSTS INDUCED IN CALCIUM-FREE MEDIUM
HNBTI had no significant effect on the bursts when 
superfused alone for 30 minutes at 100 pM. Similarly HNBTI 
proved unable to elicit a response when applied together 
with a high concentration of adenosine (2 mM) in calcium- 
free medium (figure 3.21.).
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Figure 3.20. Histogram showing the effect of S-(2-Hydroxy- 
5-nitrobenzy1)-6-thioinosine (HNBTI) and adenosine (AD) on 
orthodromically evoked CA1 population spikes (P.S.) in 
normal ACSF. Each vertical bar represents the mean ± s.e.m. 
for n=5. A paired t test was employed to determine the 
significance level( * = P<0.05; **=P<0.01).
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Figure 3.21. Histogram showing the effect of S-(2-Hydroxy- 
5-nitrobenzyl)-6-thioinosine (HNBTI) and adenosine (AD) on 
antidromically evoked CA1 secondary spikes (S.S.) in 
calcium-free medium. Each vertical bar represents the mean 
± s.e.m. for n=3. A paired t test was employed to determine 
the significance level, n. s .=non-significant.
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3.1.15. E F F E C T  OF T H A P S I G A R G I N  O N  R E S T O R A T I O N  OF A D E N O S I N E
I N H I B I T O R Y  E F F E C T  IN C A L C I U M - F R E E  M E D I U M
Since postsynaptic adenosine sensitivity was restored 
in a low amount calcium, thapsigargin was used to clarify 
the site of calcium action.
Thapsigargin, which discharges intracellular calcium 
stores by inhibition of the endoplasmic reticulum calcium 
ATPase, had no significant effect on the antidromic evoked 
secondary spike size when applied alone at a concentration 
of 1 m-M, or when superfused with adenosine 0.5 mM for 10 
minutes in calcium-free medium (figure 3.22.).
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Figure 3.22. Histogram showing the effect of thapsigargin 
and adenosine on antidroraically evoked CA1 secondary spikes 
(S.S.) in calcium-free medium. Each vertical bar represents 
the mean ± s.e.m. for n=3. A paired t test was employed to 
determine the significance level, n .s .=non-significant.
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3.1.16. I N H I B I T O R Y  E F F E C T  OF N 6- C Y C L O P E N T Y L A D E N O S I N E  (CPA)
Although adenosine Aj receptor generally have inhibitory 
effects, adenosine A2 receptors can depolarize the cells and 
show excitatory effects. For this reason the highly 
selective Aj adenosine receptor agonist, CPA, was tested.
3.1.16.1. EFFECT OF CPA ON ORTHODROMIC POPULATION SPIKES
CPA induced a concentration-dependent reduction in the 
amplitude of orthodromic population potentials (figure 
3.23.). The maximum effect was seen at about 30 nM. The Aj 
agonist had no effects on presynaptic fiber volley. CPA was 
applied for 25 minutes, since CPA required 15-20 minutes 
both to achieve a stable response size, and for recovery 
after washout.
3.1.16.2. EFFECT OF CPA ON ANTIDROMIC BURSTS INDUCED IN 
CALCIUM-FREE MEDIUM
In nominally calcium-free medium CPA at concentrations 
of 100-200 nM had no significant effect on antidromic first 
and secondary spike size (figure 3.23.).
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Figure 3.23. Cumulative concentration-response curve of N^- 
cyclopentyladenosine (CPA) on orthodromically evoked CA1 
population spikes (P.S.) in normal ACSF and on 
antidromically evoked CA1 secondary spikes (S.S.) in 
calcium-free medium. Each point represents the mean ± 
s.e.m. for n=3 for CPA. A paired t test was employed to 
determine the significance level (*=P<0.05; m =P<0.001).
St.=Stimulation.
101
3.1.17. E F F ECTS OF S T A B I L I Z E R  A G E N T S  O N  R E S T O R A T I O N  OF
A D E N O S I N E  P O S T S Y N A P T I C  S E N S I T I V I T Y  IN C A L C I U M - F R E E  M E D I U M
Because omitting calcium destabilizes the cell 
membrane, two stabilizer agents, procaine and carbamazepine 
were examined on responses to adenosine.
3.1.17.1. EFFECT OF PROCAINE ON POSTSYNAPTIC SENSITIVITY TO 
ADENOSINE IN CALCIUM-FREE MEDIUM
Procaine, at 100 pM decreased reversibly the amplitude 
of both first and secondary antidromic spikes (12.04% ± 
1.95, P<0.01, n=4 and 17.26% ± 4.014, P<0.05, n=4)
respectively. A higher concentration of 500 pM procaine 
completely abolished both first and secondary spikes. The 
effect of procaine became stable after about 5-10 minutes. 
When combined with adenosine, procaine was superfused for 15 
minutes before addition of the purine. Although 100 pM 
adenosine had no effect alone on the antidromic potential, 
its combination with procaine 100 pM decreased secondary 
spikes (figure 3.24.).
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Figure 3.24. Histogram showing the effect of adenosine (AD) 
and procaine on antidromically evoked CA1 secondary spikes 
(S.S.) in calcium-free medium. Each vertical bar represents 
the mean ± s.e.m. for n=4. A paired t test was employed to 
determine the significance level (*=P<0.05; **=P<0.01).
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3.1.17.2.1. EFFECT OF CARBAMAZEPINE ON POSTSYNAPTIC 
SENITIVITY OF ADENOSINE IN CALCIUM-FREE MEDIUM
In nominally calcium-free medium, carbamazepine, at 50 
or 100 pM, concent rat ion-dependent ly decreased the first and 
secondary antidromic spike size. The effect of carbamazepine 
became prominent and stable after about 10 minutes. Complete 
washout of carbamazepine took more than 30 minutes.
Carbamazepine was applied 15 minutes before superfusion 
of adenosine. Carbamazepine restored the effect of adenosine 
sensitivity in calcium-free medium (figure 3.25. and 3.26.).
3.1.17.2.2. INTERACTION OF CARBAMAZEPINE AND BACLOFEN ON 
BURSTS INDUCED IN CALCIUM-FREE MEDIUM
Carbamazepine at concentration of 50 pM did not 
increase the inhibitory effect of 20 pM baclofen (figure 
3.21) .
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Figure 3.25. Histogram showing the effect of adenosine (AD) 
and carbamazepine (CBZ) on antidromically evoked CA1 
secondary spikes (S.S.) in calcium-free medium. Each 
vertical bar represents the mean ± s.e.m. for n>4. A paired 
t test was employed to determine the significance level 
(*=P<0 . 05 ; ** = P<0.01).
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Figure 3.27. Histogram showing the effect of baclofen (Bac) 
and carbamazepine (CBZ) on antidromically evoked CA1 
secondary spikes (S.S.) in calcium-free medium. Each 
vertical bar represents the mean ± s.e.m. for n=4. A paired 
t test was employed to determine the significance level 
(* = P<0.05; **=P<0.01). n . s . =non-s igni f icant.
107
3.1.18. E F F E C T  OF M E T H Y L X A N T H I N E S  IN C A L C I U M - F R E E  M E D I U M
3.1.18.1.1. EFFECT OF ADENOSINE AND THEOPHYLLINE ON 
ORTHODROMIC POTENTIALS
Adenosine at 50 pM abolished completely the orthodromic 
population spikes. Theophylline, a non-selective adenosine 
receptor antagonist, at a concentration of 50 pM alone 
increased population spikes by 21.17% ± 6.24 (P<0.05, n=4). 
The effect of theophylline began after about 3-5 minutes and 
recovery on washout took more than 15 minutes. Theophylline 
did not induce secondary spikes in any of the slices. In the 
presence of theophylline 50 pM, adenosine now reduced the 
population spikes by 69.93% ± 3.25 (P<0.01, n=4, figure
3.28) .
3.1.18.1.2. EFFECT OF ADENOSINE AND THEOPHYLLINE ON 
ANTIDROMIC BURSTS INDUCED IN CALCIUM-FREE MEDIUM
In calcium-free medium theophylline, 50 pM unexpectedly 
decreased the size of the first antidromic spike size by 
29.96% ± 5.67 and secondary spike size by 50.61% ± 6.79
(PcO.001, n=14). In 4 slices washout of theophylline 50 pM 
even for 30 minutes did not restore the size of secondary 
spikes to control. In four other slices the first and 
secondary spike dramatically decreased within 2-3 minutes 
and then they were increased but the size did not 
recover to control. Adenosine at 200 pM had no effect itself 
in calcium-free medium but prevented the inhibitory effect 
of the xanthines (figures 3.29).
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Figure 3.28. Histogram showing the effects of adenosine 
(AD) and theophylline on orthodromically evoked CA1 
population spikes (P.S.) in normal ACSF. Each vertical bar 
represents the mean ± s.e.m. for n=4. A paired t test was 
employed to determine the significance level (*=P<0.05; 
**=P<0 .01; m =P<0.001) .
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Figure 3.29. Histogram showing the effects of adenosine 
(AD) and theophylline on antidromically evoked CA1 
secondary spikes (S.S.) in calcium-free medium. Each 
vertical bar represents the mean ± s.e.m. for n=4. A paired 
t test was employed to determine the significance level
(** = P<0.01 ; ***=P<0.001) .
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3 . 1 . 1 8 . 1 . 3  E F F E C T  OF  T H E O P H Y L L I N E  O N  A N T I D R O M I C  F I E L D  A C T I O N
P O T E N T I A L  IN N O R M A L  A C S F
In normal calcium-containing ACSF, theophylline, 50 pM 
slightly increased the size of the first antidromic spike by 
5.64% ± 2.01 (P<0.05, n=6)
3.1.18.1.4. INTERACTION OF THEOPHYLLINE AND BICUCULLINE ON 
ANTIDROMIC FIELD ACTION POTENTIAL IN NORMAL ACSF
In order to study the effect of theophylline on 
secondary spikes in the presence of calcium, bicuculline, a 
GABAa antagonist was used for induction of bursts.
Bicuculline 10 pM quickly induced secondary spikes in 
less than three minutes, and after about 5-10 minutes stable 
bursts with 3-6 secondary spike were stablished. Washout of 
bicuculline took more than 30 minutes.
Theophylline 50 pM did not decrease the first (0.65% ±
1.4, P=0.66, n.s.) or secondary (0.67% ± 1.99, P=0.74, n.s.) 
antidromic spikes induced by bicuculline (n=6) . The 
methylxanthine also induced spontanous activity in 3-5 
minutes (4.14 ± 1.01 spikes/minute, n=6, P<0.01).
Ill
3.1.18.2.1. EFFECT OF ADENOSINE AND 8-CYCLOPENTYL-l,3- 
DIMETHYLXANTHINE (CPT) ON ORTHODROMIC POTENTIAL
CPT, an A 1 receptor antagonist, at a concentration of 
100 nM antagonized responses to adenosine 50 pM, which now 
reduced the population spike by only 22.77% ± 3.22
(P<0.001, n=6, figure 3.30.). The effect of CPT was slower 
in onset than theophylline, taking about 10 minutes, and 
recovery on washout took more than 30 minutes.
3.1.18.2.2. EFFECT OF ADENOSINE AND CPT ON ANTIDROMIC 
STIMULATION INDUCED IN CALCIUM-FREE MEDIUM
In calcium-free medium CPT 100 nM decreased the size of 
the first antidromic spike size by 17.91% ±3.73 (P<0.05,
n=4) and secondary spike size by 50.56% ± 11.45 (P<0.05,
n=4, figure 3.31.).
Adenosine at 200 pM had no effect itself in calcium - 
free medium but prevented the inhibitory effect of the 
xanthine (figure 3.31.).
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Figure 3.30. Histogram showing the effects of adenosine 
(AD) and 8-cyclopenty1-1,3-dimethylxanthine (CPT) on 
orthodromically evoked CA1 population spikes (P.S.) in 
normal ACSF. Each vertical bar represents the mean ± s.e.m. 
for n=6. A paired t test was employed to determine the 
significance level (m =P<0.001).
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Figure 3.31. Histogram showing the effects of adenosine 
(AD) and 8-cyclopentyl-l,3-dimethylxanthine (CPT) on 
antidromically evoked CA1 secondary spikes (S. S.) in 
calcium-free medium. Each vertical bar represents the mean 
± s.e.m. for n=4. A paired t test was employed to determine 
the significance level (*=P<0.05).
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3.1.18.3. M E C H A N I S M ( S )  OF  P A R A D O X I C A L  E F F E C T  OF  X A N T H I N E S  IN
C A L C I U M - F R E E  M E D I U M
As mentioned above theophylline showed two opposite 
effects,- an expected excitatory one when examined with 
orthodromic stimulation in normal ACSF, but an inhibitory 
one when tested on antidromic responses to antidromic 
stimulation in calcium-free medium. We therefore attempted 
to examine the reasons for this differenc.
115
3.1.18.3.1. EFFECT OF THEOPHYLLINE ON ANTIDROMIC BURSTS IN 
LOW CALCIUM MEDIUM (0.1 mM)
Adding 0.1 mM calcium had no significant effect on 
secondary spike size established in calcium-free medium. 
However, at this concentration calcium reduced the 
inhibitory effect of theophylline to 16.3% ± 1.49 (P<0.001, 
n=5, figure 3.32). Calcium did slightly but significantly 
increase the size of the primary antidromic spike and again 
abolished the inhibitory of theophylline (figure 3.33.).
3.1.18.3.2. EFFECT OF CPT ON ANTIDROMIC BURSTS IN CALCIUM- 
FREE MEDIUM PLUS 1 mM EGTA
Adding 1 mM EGTA to calcium-free medium decreased 
secondary spike size significantly by 14.82% ± 4.69 (P<0.05, 
n=7) and also reduced bursts with four or three spikes down 
to two spikes. CPT 100 nM decreased secondary spike size by 
29.79% ± 2.52 (P<0.001, n=5) in calcium-free medium. In
calcium-free media with 1 mM EGTA, CPT decreased secondary 
spike size by 45.60% ± 5.63 (P<0.01, n=7) which was
significant when compared to EGTA alone in calcium-free 
media (figure 3.34.).
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Figure 3.32. Histogram showing the effect of theophylline 
on antidromically evoked CA1 first spike (F.S.) size in 
calcium-free medium or 100 pM calcium. Each vertical bar 
represents the mean ± s.e.m. for n=5. A paired t test was 
employed to determine the significance level (*=P<0.05; 
**=P<0.01) .
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Figure 3.33. Histogram showing the effect of theophylline 
on antidromically evoked CA1 scondary spike (S.S.) size in 
calcium-free medium or 100 n,M calcium. Each vertical bar 
represents the mean ± s.e.m. for n=5. A paired t test was 
employed to determine the significance level (**=P<0.01; 
m =P<0.001) .
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Figure 3.34. Histogram showing the effects of 8- 
cyclopenty1-1,3-dimethylxanthine (CPT) on antidromically 
evoked CA1 secondary spikes (S.S.) in calcium-free medium 
and calcium-free media plus 1 mM EGTA. Each vertical bar 
represents the mean ± s.e.m. for n=5-7. A paired and 
unpaired t test was employed to determine the significance 
level (*=P<0 . 05 ; ** = P<0.01, m =P<0 . 001) .
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3.1.18.3.3. I N T E R A C T I O N  OF B A C L O F E N  A N D  T H E O P H Y L L I N E  O N
A N T I D R O M I C  B U RSTS INDUCED IN C A L C I U M - F R E E  M E D I U M
Baclofen, a GABAg agonist, at 5 pM had no effect on the 
size of secondary spikes but prevented the inhibitory action 
of theophylline on secondary spike size (P<0.05, n=6,
figures 3.35. and 3.36.).
3.1.18.3.4.1. INTERACTION: OF CARBAMAZEPINE AND THEOPHYLLINE 
ON ANTIDROMIC BURSTS INDUCED IN CALCIUM-FREE MEDIUM
Carbamazepine, 50 pM decreased slightly the size of the 
first and secondary spikes by 8.49% ± 2.22 (P<0.05, n=6) and 
17.66% ± 4.87 (P<0.05, n=6) respectively. At this
concentration carbamazepine completely blocked the
depression induced by theophylline, 50 pM in calcium-free 
medium (figure 3.37.).
3.1.18.3.4.2. EFFECT OF CARBAMAZEPINE ON THE EXCITATORY 
EFFECT OF THEOPHYLLINE ON ORTHODROMIC SPIKES IN NORMAL ACSF
The excitatory activity of theophylline, 50 pM was 
still seen in the presence of carbamazepine, 50 pM and was 
not significantly different from that seen with theophylline 
alone (P=0.568, n=6)
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Figure 3.35. Histogram showing the effects of baclofen and 
theophylline on antidromically evoked CA1 secondary spike 
(S.S.) size in calcium-free medium. Each vertical bar 
represents the mean ± s.e.m. for n=6. A paired t test was 
employed to determine the significance level (**=P<0.01).
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Figure 3.37. Histogram showing the effects of theophylline 
and carbamazepine (CBZ) on antidromically evoked CA1 
secondary spikes (S.S.) in calcium-free medium. Each 
vertical bar represents the mean ± s.e.m. for n=6. A paired 
t test was employed to determine the significance level
(*=P<0 . 05 ; **=P<0.01).
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3.1. 1 8 . 3 . 5 .  E F F E C T  OF T H E O P H Y L L I N E  O N  IS O L A T E D  CA1
A N T I D R O M I C  BURSTS IN C A L C I U M - F R E E  M E D I A
Since there is a possibility that theophyl1ine.induced 
pacemaker activity in the CA3 region could cause the 
inhibitory effect on secondary spikes in calcium-free media, 
CA3 and CA1 regions were disconnected and the effect of 
theophylline on the isolated CA1 area was studied.
Theophylline 50 pM decreased both antidromic first and 
secondary spikes by 19.83% ± 4.45 (P<0.05) and 45.11% ± 7.62 
(P<0.01, n=4). These results were not significant when
compared (unpaired t-test) with the results of theophylline 
in intact slices (n=9, figure 3.38.).
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Figure 3.38. Histogram showing a comparison of the effect 
of theophylline 50 pM on first (F.S.) and secondary spikes 
(S.S.) on intact slices or isolated slices with CA3 
disconnected from CA1 in calcium-free medium. Each vertical 
bar represents the mean ± s.e.m. for n=4 and 9 for isolated 
and intact slices respectively. A paired and unpaired t 
test was employed to determine the significance level 
(* = P<0.05; **=P<0.01; ***=P<0 . 001) . n . s . =non-s igni f icant.
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3.1.18.3.6.1.1. EFFECT OF ADENOSINE DEAMINASE ON ORTHODROMIC 
EFFECT OF ADENOSINE IN NORMAL ACSF
Adenosine 50 or 100 pM completely abolished orthodromic 
induced P.S. size. Application of adenosine deaminase (ADA) 
at a concentration 0.25 IU/ml for 20 minutes had no 
significant effect on the orthodromic potential. Perfusion 
of slices with ADA at this concentration was sufficient to 
prevent completely the inhibitory effect of 50 pM (n=2) or 
100 pM (n=l) adenosine on orthodromic potentials.
Application of adenosine 50 pM again completely 
abolished the P.S size after 30 minutes washout of slice 
with normal ACSF.
3.1.18.3.6.1.2. EFFECT OF THEOPHYLLINE ON ANTIDROMIC BURSTS 
INDUCED IN CALCIUM-FREE MEDIUM IN THE PRESENCE OF ADENOSINE 
DEAMINASE
Adenosine deaminase at a concentration of 0.25 IU/ml 
had only a slight depressant effect upon secondary spike 
size (7.94% ± 3.08, P=0.05, n=6), and did not modify the
inhibitory effect of theophylline in calcium-free medium 
(f igure 3.39) .
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Figure 3.39. Histogram showing the effects of theophylline 
and adenosine deaminase (ADA) on antidromically evoked CA1 
secondary spikes (S.S.) in calcium-free medium. ADA did not 
prevent the inhibitory effect of theophylline on S.S. size. 
Each vertical bar represents the mean ± s.e.m. for n=6. A 
paired t test was employed to determine the significance 
level (*=P=0.05; m =P<0.001). n .s .=non-significant.
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l l E C r n m  11 : PiJARMACOLOGiC/VL . ANALYIM'J OP 
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3.2. INTERACTION OF A POTASSIUM CHANNEL BLOCKER OR OPENER 
WITH ADENOSINE OR BACLOFEN
Since adenosine lost its inhibitory effect on secondary 
spikes in calcium-free media but baclofen did not, the 
postsynaptic sensitivity of these agonists to potassium 
channel blockers or openers was studieed.
3.2.1. INTERACTION OF ADENOSINE AND APAMIN ON ORTHODROMIC 
POPULATION SPIKES
If adenosine hyperpolarizes the soma via calcium- 
activated potassium channels, there is a possibility that 
this agonist will lose its effect in the absence of calcium. 
The effect of apamin, a selective blocker of small 
conductance calcium-activated potassium channels was 
therefore studied.
Bath application of 10 nM apamin had no significant 
effect on orthodromic CA1 field potentials (n=4). This
concentration apamin reduced the relaxant effect of ATP on 
the carbachol contracted taenia coli of the guinea pig 
(Brown & Burnstock, 1981). At higher concentration, 250 nM
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apamin did not have a consistent effect on orthodromic
potentials. In two slices it had no significant effect and 
in the rest of the slices (n=5) it increased the population 
spikes. Overall apamin had no significant effect on the
field potential (n=7, P>0.5, n.s.)
Apamin at a concentration of 250 nM (n=3, 12.37% ±
9.10, n.s.) had no significant effect on the inhibitory
effect of adenosine 5 pM on orthodromic population spikes 
(figure 3.40.).
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Figure 3.40. Histogram showing interaction of adenosine and 
apamin on orthodromically evoked CA1 population spikes in 
normal ACSF. Each vertical bar represents the mean ± s.e.m. 
for n=3. A paired t test was employed to determine the 
significance level (m =P<0.001). n .s .=non-significant.
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3.2.2. EFFECT OF ADENOSINE IN THE PRESENCE OF TOLBUTAMIDE
3.2.2.1 INTERACTION OF ADENOSINE AND TOLBUTAMIDE ON
OTHODROMIC POPULATION SPIKES
Adenosine at 5 and 10 pM reduced the amplitude of 
orthodromic population spikes by 36.69% ± 3.56 (P<0.01, n=4) 
and 56.93% ± 2.2 (n=4, P<0.001) respectively. Tolbutamide
0.5 and 1 mM alone increased the population spikes size- by 
6.89% ± 4.07 (n.s., n=3) and 12.48% ± 3.81 (n=4, P<0.05)
respectively. This effect was seen in less than 5 minutes. 
Tolbutamide 1 mM significantly decreased the effect of 
adenosine 10 pM to 32.96% ± 5.79 and markedly but not
significantly decreased the response to adenosine 5 pM (n=4, 
P<0.05, figure 3.41).
3.2.2.2. INTERACTION OF ADENOSINE AND TOLBUTAMIDE ON
ORTHODROMIC FIELD EPSPs (fEPSPs)
The inhibitory effect of adenosine was less on fEPSP 
size than population spike size. Adenosine at 10 and 20 mM
decreased the size of the field EPSPs 13.23% ± 3.13 (n=4,
P<0.05) and 39.97% ± 1.28 (n=4, P<0.001). Tolbutamide, 1 mM 
did not affect this presynaptic effect of adenosine at 
either concentration (n=4, figure 3.42.). Tolbutamide alone 
increased slightly the size of field EPSPs by 6.41% ± 1.99 
(n=4, P<0.05).
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Figure 3.41. Histogram showing the effect of adenosine (AD) 
and tolbutamide (TLB) on orthodromically evoked CA1 
population spikes (P.S.) in normal ACSF. Each vertical bar 
represents the mean ± s.e.m. for the number of slices 
indicated in parentheses. A paired t test was employed to 
determine the significance level relative to control 
potentials or to adenosine alone as indicated ( =P<0.05; 
**=P<0.01; m =P^0 . 001) . n . s . =non-s igni f icant.
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Figure 3.42. Histogram showing the effect of adenosine (AD) 
and tolbutamide (TLB) on orthodromically evoked CA1 field 
EPSPs in normal ACSF. Each vertical bar represents the mean 
± s.e.m. for n=4. A paired t test was employed to determine 
the significance level (*=P<0.05; **=P<0.01; *** = P<0.001) .
n.s.= non significant.
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3.2.2.3. I N T E R A C T I O N  OF A D E N O S I N E  A N D  T O L B U T A M I D E  ON
A N T I D R O M I C  BURSTS IN D U C E D  IN C A L C I U M - F R E E  H I G H  M A G N E S I U M
M E D I U M
Adenosine at 5 and 10 piM decreased antidromic secondary 
spike size induced in calcium-free high magnesium media by 56.07% 
± 12.75 (n=4, P<0.05) and 76.26% ± 14.67 (n=4, P<0.05).
Tolbutamide 1 mM decreased the effect of adenosine 
dramatically to 9.13% ± 2.63 (n=4, P<0.05) and 15.36% ± 1.20 
(n=4, P<0.05) respectively (figure 3.43 and 3.44.).
Tolbutamide alone increased the size secondary spikes by 
18.88% ± 7.43 (n.s. , n=4) .
Washout of tolbutamide 1 mM was quick and the normal 
inhibitory effect of adenosine was seen in about 5 minutes.
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Figure 3.43. Histogram showing the effect of adenosine and 
tolbutamide (TLB) on antidromically evoked CA1 secondary 
spikes (S.S.) in calcium-free medium containing 4 mM 
magnesium. Each point represents the mean ± s.e.m. for n=4. 
A paired t test was employed to determine the significance
level (*=P<0.05; m =P<0.001)
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3.2.3. E F F E C T  OF B A C L O F E N  IN T H E  P R E S E N C E  OF  T O L B U T A M I D E
3.2.3.1. INTERACTION OF BACLOFEN AND TOLBUTAMIDE ON 
ORTHODROMIC POPULATION SPIKES
Baclofen at 1 and 2 pM reduced the amplitude of 
population spikes by 16.90% ± 1.35 (n=4, p<0.001) and 46.87% 
± 5.15 (n=4, P<0.01) respectively. Tolbutamide had no
significant effect on the inhibitory effect of baclofen 1 pM 
and 2 pM (n=4) and itself increased the size of potential by 
8.91% ± 2.73 (P<0.05, n=4, figure 3.45.).
3.2.3.2. INTERACTION OF BACLOFEN AND TOLBUTAMIDE ON 
ANTIDROMIC BURSTS INDUCED IN CALCIUM-FREE HIGH MAGNESIUM 
MEDIUM
Baclofen at concentrations 1, 2 and 5 pM decreased
secondary spike size by 36.91% ± 7.65 (P<0.05, n=4), 73.06% 
± 15.06 (P<0.05, n=4) and 96.92% ± 1.26 (P<0.001, n=4) .
Tolbutamide 1 mM had no significant effect on these 
inhibitory actions of baclofen and alone increased the 
amplitude of secondary spikes by 25.95% ± 7.67 (P<0.05, n=4, 
figure 3.46.) in this series of experiments.
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Figure 3.45. Histogram showing the effect of baclofen (BAC) 
and tolbutamide (TLB) on orthodromically evoked CA1 
population spikes (P.S.) in normal ACSF. Each vertical bar 
represents the mean ± s.e.m. for n=4. A paired t test was 
employed to determine the significance level (*=P<0.05; 
**=P<0.01; m  = P<0 . 001) . n.s.= non significant.
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Figure 3.46. Effect of baclofen (BAC) and tolbutamide (TLB) 
on antidromically evoked CA1 secondary spikes (S.S.) in 
calcium-free medium containing 4 mM magnesium. Each 
vertical bar represents the mean ± s.e.m. for n=4. A paired 
t test was employed to determine the significance level 
(* = P<0.05; ***=P^0 . 001) . n.s= non-significant.
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3.2.4.1. INTERACTION OF ADENOSINE AND LEVCROMAKALIM ON 
ORTHODROMIC POPULATION SPIKES
Levcromakal im at a concentration of 100 pM had no 
significant effect itself on orthodromic population spike 
size of CA1 pyramidal cells (9.26% ± 4.99, n=5, p=0.269,
n.s.) but it reversibly potentiated the inhibitory effect of 
adenosine on the potential size (figure 3.47.).
3.2.4.2. INTERACTION OF BACLOFEN AND LEVCROMAKALIM ON 
ORTHODROMIC POPULATION SPIKES
In another series of experiments, levcromakalim 100 pM 
decreased population spikes slightly by 7.35% ± 1.91
(P<0.05, n=5) but did not change the inhibitory effect of 
baclofen applied at 1 or 2 pM (figure 3.48.).
3.2.4.3. INTERACTION OF LEVCROMAKALIM AND TOLBUTAMIDE ON 
ORTHODROMIC POPULATIUON SPIKES
Tolbutamide 1 mM increased population spike size. 
Levcromakalim 100 pM had no significant effect on the size 
of population spikes but decrease the excitatory effect of 
tolbutamide (figure 3.49.).
140
CD
N
m
co
CD
CO
co
CD
S-H
o
CD
Q
Levcromakalim (LCRK) 100  /i,M  
Adenosine (AD) 2 jllM
A d  2 +  LCRK 100 juM
100 r  ^  AD 5 ytxM 
AD 5 jliM  -+- LCRK 100 yuM
80
60
40
X
++
Figure 3.47 Histogram showing the effect of adenosine (AD) 
and levcromakalim (LCRK) on orthodromically evoked CA1 
population spikes (P.S.) in normal ACSF. Each vertical bar 
represents the mean ± s.e.m. for n=5. A paired t test was 
employed to determine the significance level (*=P<0.05; 
**=P<0 . 01) .
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Figure 3.48. Histogram showing the effect of baclofen (BAC) 
and levcromakalim (LCRK) on orthodromically evoked CA1 
population spikes (P.S.) in normal ACSF. Each vertical bar 
represents the mean ± s.e.m. for n=5. A paired t test was 
employed to determine the significance level (*=P<0.05; 
** = P<0.01; ***=P<0 . 001) . n.s.= non-significant.
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Figure 3.49. Histogram showing interaction of tolbutamide 
(TLB) and levcromakalim (LCRK) on orthodromically evoked 
CA1 population spikes (P.S.) in normal ACSF. Each vertical 
bar represents the mean ± s.e.m. for n=5. A paired t test 
was employed to determine the significance level (*=P<0.05). 
n.s.= non-significant.
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4.1. LOSS OF  A D E N O S I N E  P O S T S Y N A P T I C  S E N S I T I V I T Y  IN C A L C I U M -
F R E E  M E D I U M
The main finding of this study was that the 
sensitivity, of postsynaptic neurones to adenosine, as 
reflected in suppression of epileptiform burst discharges, 
was lost by removing the calcium.
In line with other literature, lowering or omitting 
calcium allowed CA1 pyramidal neurones to generate 
epileptiform bursts after antidromic stimulation (Haas & 
Jefferys, 1984; Taylor & Dudek, 1984). In normal ACSF, 
recurrent, feedforward inhibition and calcium dependent 
potassium mediated afterhyperpolarization oppose sustained 
neuronal discharges. Lowering extracellular calcium reduces 
these normal processes and bursts of action potentials 
appear (Agopyan and Avoli, 1988; Heinemann et al. , 1992).
Lowering calcium of the medium removes the stabilisation 
effect of calcium on the membrane surface charges 
(Begenisich, 1988; Frankenhaeuser & Hodgkin, 1957).
Measurement with ion-selective electrodes during the 
field bursts showed thatjextracellular potassium increased 
and extracellular sodium decreased (Yaari et al. , 1983;
Haas and Jefferys, 1984).
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The action of calcium on the system controlling sodium 
and potassium permeability probably explains its effect on 
excitability. A nerve becomes more excitable in low 
calcium, because a smaller depolarization is required to 
increase the sodium conductance to the critical level at 
which the inward sodium current exceeds the outward current 
carried by potassium and other ions (Frankenhaeuser & 
Hodgkin, 1957) .
Orthodromic population spikes were suppressed by 
changing from ACSF to nominally calcium-free or low calcium 
medium. In fact synaptic transmission was abolished with 
the removing of calcium. Thus this model of antidromic 
bursts induced in calcium-free medium is independent of 
synaptic activity and the inhibitory effects of agents 
refers to their postsynaptic activity.
The finding that slices become much more sensitive to 
reperfusion of calcium-free media after the productionof 
full bursts with calcium-free or high potassium media and 
washout with normal ACSF may be related to some kind of 
kindling phenomenon.
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4.1.1. ROLE OF THE CHANGE OF UPTAKE OR METABOLISM OF 
ADENOSINE ON THE LOSS OF ITS SENSITIVITY IN CALCIUM-FREE 
MEDIUM
The loss of adenosine sensitivity in calcium-free 
media is unlikely to be due to a change of uptake or 
metabolism of adenosine because 2-chloroadenosine and R- 
PIA, which are not substrates for either the nucleoside 
transporters or adenosine deaminase, were equally inactive 
in the absence of calcium. Similarly the lack of effect of 
HNBTI, an adenosine transport inhibitor (Hertz, 1991), 
showed that adenosine transport did not change or has no 
role in the loss of adenosine sensitivity.
4.1.2. ROLE OF HYPEREXCITABILITY ON THE LOSS OF ADENOSINE 
SENSITIVITY IN CALCIUM-FREE MEDIUM
The loss of efficacy of adenosine and its analogues 
CPA, R-PIA and 2CAD0 in calcium-free medium is not only due 
to the neuronal hyperexcitability because increasing the 
applied concentration up to as much as 5 mM adenosine or 
high concentrations of its analogues proved ineffective. 
Equally, reducing secondary spike size to a clearly 
submaximal level (less than 50% of maximum) did not restore 
any adenosine effect.
Of great interest are the results of combining 
adenosine with baclofen. When applied together with
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baclofen, 20 pM which decreased secondary spikes about 50%, 
adenosine had no greater effect than when applied alone, 
supporting the earlier conclusion that adenosine’s
inactivity is not simply the result of neuronal
hyperexcitability. The postsynaptic activity of these 
agonists will be explained more in section 4.3.2.
Stone et al. (1992) introduced one possibility of
explaining the apparent excitatory activity of adenosine in 
no-magnesium low calcium (1.2 mM) , on the basis that 
spontaneous bursts could suppress evoked potential size. If 
adenosine then inhibited spontaneous bursting, it could 
induce an increase of evoked potentials, or at least have 
its inhibitory activity masked. This phenomenon is not 
likely to explain the present loss of adenosine sensitivity 
since, even when the CA1 region was isolated from CA3 (the 
site of origin of most hippocampal bursts), adenosine still 
had no significant effect on secondary spikes in calcium- 
free medium.
4.1.3. ROLE OF EXCITATORY AMINO ACIDS IN CALCIUM-FREE 
MEDIUM
Another possible explanation which was considered, was 
that some release of transmitters might continue in the 
absence of calcium. Besides the universal release of 
neurotransmitters by calcium-dependent exocytosis, the 
alternative mechanism is sodium-sensitive efflux. For
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i i+
example, Na influx through Ca channels can promote 
striatal GABA efflux in the absence of extracellular 
calcium in response to electrical field depolarization 
(Bernath et al., 1993). Excitatory amino acids participate 
in the initiation of seizures and their propagation 
(Dingledine et al ., 1990). The release of glutamate might 
activate the population of receptors sensitive to N-methyl- 
D-aspartate (NMDA), an action which has been found to 
diminish responses to adenosine (Bartrup & Stone, 1990; 
Bartrup et_ al., 1991). Such an explanation might also
account for the ability of raised magnesium concentrations 
to increase adenosine responsiveness. Kynurenic acid, the 
excitatory amino acid antagonist (Perkins & Stone, 1984; 
Stone, 1993) at a concentration one tenth of that used in 
calcium-free media profoundly decreased orthodromic 
population spikes, presumably due to non-selective 
antagonism of excitatory amino acids in CA1 region (Stone, 
1990) . However, addition of kynurenic acid had no effect 
on burst induced by calcium-free or low calcium media.
The failure of kynurenic acid to prevent antidromic 
bursts does not exclude the calcium independent release of 
excitatory amino acids but at least shows they are not 
involved in this kind of burst.
Adenosine concentration-dependently decreased 
antidromic secondary spikes in high potassiuntand normal Ca2+. 
The mechanism of these bursts may be related to: 1) decrease in
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the amplitude of K+-mediated burst afterhyperpolarization; 
2) decrease in the amplitude of GABAergic IPSPs, probably 
secondary to a rise in intracellular [Cl"] ; 3)
depolarization of pyramidal cells. These situations can 
enhance the activation of NMDA receptors by excitatory 
transmitters acting on CA1 pyramidal cells during bursts 
(Traynelis & Dingledine, 1988). The nature of this kind of 
burst is different from calcium-free bursts, since 
kynurenic acid abolished them, indicating the role of amino 
acids. Nevertheless, it is clear that, despite release of 
excitatory amino acids, adenosine was still active to 
reduce the secondary spikes. This supports the idea that 
the loss of adenosine sensitivity in calcium-free media is 
not related to the release of excitatory amino acids.
4.1.4. ROLE OF A2 RECEPTORS IN THE LOSS OF ADENOSINE 
SENSITIVITY IN CALCIUM-FREE MEDIA
Bartrup and Stone (1988) showed that in the magnesium- 
free, reduced calcium solutions adenosine produced an 
increase of population spike size in half of the slices 
tested. This action was mimicked by NECA, which has similar 
potency at adenosine Aj and A2 receptors. The authors 
concluded that removal of magnesium prevents the activation 
of the Aj receptor and unmasks activation of an A2 receptor. 
In rat striatum slices, CPA induced a rapid functional loss 
of Aj receptors (inhibitory on cAMP production time and dose 
dependently) which was accompanied by a concomitant
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increase of A2 receptor-mediated stimulation of cyclase 
activity. Aj adenosine receptor desensitization is 
characterized by initial loss of receptor function in the 
absence of any change of receptor number or G-protein 
defect (Abbracchio et al., 1992). In the hippocampus the A2 
agonist, CGS21680, induced an excitatory effect in CA1 
pyramidal cells of hippocampal slices (Sebastiao & Ribeiro,
1992) . However the very selective adenosine Aj receptor 
agonist, CPA had no effect on secondary spikes in calcium- 
free medium. Thus it is unlikely that A2 receptor activity 
is the reason for the loss of adenosine sensitivity.
4.1.5. EFFECT OF ADENOSINE ON ANTIDROMIC BURSTS INDUCED IN 
LOW CALCIUM OR CALCIUM-FREE PLUS MAGNESIUM
Raising or adding magnesium or calcium to calcium-free 
medium restored adenosine sensitivity of antidromic bursts. 
In calcium-free plus 4 mM magnesium, the maximum effects of 
adenosine, 20 |aM, was the same as effect of this agonist in 
normal ACSF. Other studies ( Lee et al., 1984) also showed 
that adenosine is very active in low calcium plus high 
magnesium medium to abolish secondary spike size induced by 
antidromic stimulation in the CA1 region of the hippocampal 
slice. Also, intracellular recordings from cell bodies 
showed that adenosine can hyperpolarize the cell 
effectively, confirming the efficacy of adenosine at 
postsynaptic sites (Greene & Haas, 1985; Okada & Ozawa, 
1980; Segal, 1982; Thompson et al., 1992).
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One of the earliest demonstrations of an interaction 
of cations and adenosine was the effect of magnesium on 
inhibitory actions of adenosine on adenylate cyclase 
activity in platelets (Londos & Wolff, 1977). Biochemical 
studies have shown that divalent cation such as calcium, 
magnesium and manganese could enhance Aj receptor adenosine 
binding (Goodman et al., 1982, Ukena et al., 1984; Yeung et 
al., 1984). Recently, it was also shown that the divalent
cations enhance A2 receptor adenosine binding (Ji & 
Jacobson, 1993; Johansson et a l . , 199.2; Nanoff & Stiles,
1993) .
Electrophysiological experiments by Bartup and Stone 
(1988) also supported the concept of a divalent cation 
requirement for adenosine actions by revealing that a 
reduction of extracellular magnesium concentration in the 
medium perfusing hippocampal slices could reduce the 
potency of adenosine when inhibiting synaptically evoked 
potentials. However, by studying calcium fluxes, Schubert 
et a l . (1993) have found that, in magnesium-free media, the 
inhibitory potency of adenosine was lost on stimulus 
train-evoked fluxes in the synaptic regions of the stratum 
radiatum, with much less change apparent in the pyramidal 
cell layer. This implies that the magnesium dependence of 
adenosine actions may be less marked in the cell body layer 
from which Bartrup and Stone (1988) made all their 
recordings, and that the requirement for magnesium may 
relate primarily to the inter-relationship between 
adenosine and calcium fluxes.
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Recently Smith and Dunwiddie (1993) with an
electrophysiological study of the effect of adenosine on 
fEPSP reported that alterations in cation concentrations do 
not significantly affect the sensitivity of adenosine
receptors, as long as changes are made in such a way as to
2 +leave presynaptic Ca entry unaffected. In other words, as
2+ 2+long as there is no net effect of changes in Mg and Ca 
concentrations on transmitter release, then no changes 
would be expected in adenosine sensitivity. Adenosine
sensitivity is dependent not on the absolute level of
magnesium, but on the ratio of calcium and magnesium. They 
concluded that the effects of divalent cations observed in 
ligand studies probably reflect an effect at an 
intracellular site, either on the receptor itself, or 
perhaps on associated GTP binding proteins.
The calcium-dependency of binding at GABAg receptors 
has also been reported. In rat brain the binding of [ H]GABA 
to the GABAg recognition site is dramatically stimulated by 
Ca2+ with an ECj0 of about 10 |iM. When the free Ca2+
concentration was below 22 nM, almost no binding of [ H]GABA 
to GABAg sites was detected. These effects were not mimicked 
by other cations such as Mg2+, Ba2+, La3+, Fe2+ and Zn2+
(Majewska & Chuang, 1984). In contrast, Hill and Bowery 
(1981) showed that calcium and magnesium both affect the 
binding of baclofen in rat brain. There are no studies to 
demonstrate the effect of calcium or other cations on 
binding of adenosine and baclofen in parallel but in
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independent studies the binding of both agonists are
influenced by the cations. In this electrophysiological 
studies, however, adenosine and baclofen showed completely 
different behaviour with removal of calcium. This may
favour the argument that calcium or magnesium are not
directly involved in restoration of adenosine sensitivity.
4.1.6. EFFECT OF THAPSIGARGIN ON ADENOSINE SENSITIVITY IN 
CALCIUM-FREE MEDIUM
The cation requirement of ligand binding is usually 
assumed to occur at the inner, cytoplasmic face of the cell 
membrane. The present results may indicate that a similar 
requirement exists at the extracellular face of the 
receptor. Alternatively, it may be that the removal of 
extracellular calcium also results in a depletion of 
intracellular calcium associated with membrane function. It 
was to test this hypothesis that thapsigargin was used. 
Thapsigargin inhibits the calcium-activated ATPase 
responsible for the uptake and storage of calcium in the 
endoplasmic reticulum (Inesi & Sagara, 1992); it should 
therefore, even in the absence of extracellular calcium, 
produce a rise in free intracellular calcium levels at 
least transiently, which might be expected to restore a 
temporary sensitivity to adenosine. This did not occur. It 
seems possible, therefore that if adenosine requires 
calcium it is at the external face of the membrane. This in 
turn would be consistent with the report of Greene and Haas
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(1985) that the intracellular injection of EGTA to buffer 
internal calcium did not change the hyperpolarization 
produced by adenosine.
4.1.7. EFFECT OF PD81723 ON RESTORATION OF ADENOSINE 
SENSITIVITY IN CALCIUM-FREE MEDIUM
To investigate further whether the loss of adenosine 
sensitivity in calcium-free media is related to a decrease 
of adenosine receptor binding, the adenosine binding 
enhancer, PD81723 was used. Janusz et al. (1991) showed
that PD81723 increased the binding of the Aj agonist ligand 
[ ]CHA by up to 160% in rat hippocampus. Also this agent 
which itself had no effect, potentiated the inhibitory 
effect of adenosine on orthodromic population spikes. In 
another study by this group (Janusz & Berman, 1993), 
PD81723 alone inhibited the duration of antidromic bursts 
induced in low magnesium in the in vitro hippocampal slice, 
for which 30 uM gave a maximum effect. On the contrary, in 
this study, the adenosine binding enhancer alone or with 
adenosine had no effect on secondary spikes induced in 
calcium-free medium. Thus there is the possibility that 
removal of calcium did not decrease the binding to 
adenosine receptors to cause a loss of sensitivity because 
the adenosine binding enhancer should then restore to some 
extent the binding of adenosine. It should be kept in mind 
however that this agent increased the inhibitory effect of 
adenosine on orthodromic population spikes about only 20
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percent. Other possibilities are that PD81723 binding it 
itself decreased in calcium-free medium or this agent can 
act only in situations in which adenosine is active.
4.1.8. DESENSITIZATION OF ADENOSINE
Desensitization is defined as a reduction of the 
response to a repeated or usually long-lasting stimulus 
(Lohse, 1993). It may be divided into two categories, i.e., 
’’homologous" and "heterologous" desensi tizat-ion. The former 
type refers to the situation in which there is no cross 
desensitization between different agonists and 
desensitization is specific for one kind of agonist (e.g., 
Anand-Srivastava et al. , 1989). In heterologous
desensitization, the loss of responses to one agonist may 
be accompanied by a decrease in the effect of other 
agonists (e.g., Parsons & Stiles, 1987).
Early attempts to show adenosine desensitization in 
brain slices was unsuccessful (Satin and Rail, 1970). The 
first report about desensitization of adenosine was in 
neuroblastoma cells in tissue culture (Green, 1977), 
although a clear demonstration of this phenomenon was 
reported by McNeal et al. ( 1980) in guinea-pig cerebral
cortex.
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Desensitization to adenosine has been reported in 
different tissues such as hippocampus (Lee et a l . , 1986;
Porter et al. , 1988), striatum (Abbracchio et al . , 1992,
1993; Porter et al., 1988), neocortex (Abbracchio et a l .,
1993; McNeal, 1980; Porter et al ., 1988), locus coeruleus
(Regenold & Illes, 1990), neuroblastoma (Kelly et a l ., 
1990; Kenimer & Nirenberg, 1981; ) liver (Buxton, 1987),
kidney (Newman & Levitzki, 1983), smooth muscle (Hayashi et 
a l ., 1985) vascular smooth muscle (Anand-Srivastava, 1989; 
Hussain & Mustafa, 1993), heart or myocyte (Liang & 
Donovan, 1990; Shryocck et al. , 1989), endothelial cells
(Luty et al., 1989), mast cell (Marquardt & Walker, 1987), 
adipocyte cells (Hoffman et al. , 1989; Longabaugh et al . ,
1989; Parsons & Stiles, 1987; Stoneham, 1989). Adenosine 
desensitization was seen both in vivo (Lee et al. , 1986)
and in vitro (Abbracchio et al ., 1992).
Abbracchio et al. (1992) have recently reported an 
apparent desensitization to Aj receptor binding and Porter 
et a l . ( 1988) demonstrated a decrease of A2 receptor density 
and cyclase stimulation in the striatum in vivo.
Most studies of adenosine desensitization have been 
focused on adenylate cyclase activity (e.g., Anand- 
Srivastava et al. , 1989; Kenimer & Nirenberg, 1981; Luty et 
al ., 1989), although functional effects of adenosine like
depressed effects in electrophysiological studies (Regenold 
& Illes, 1990), glycogenolysis (Buxton et al. , 1987),
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relaxation of smooth muscle (Hayashi et a l . , 1985), cardiac 
myocyte contractility (Shryock et a l ., 1989) have also been 
found to exhibit desensitization. In rat locus coeruleus 
neurones, intracellular recording showed that adenosine 
reduced the firing rate and caused hyperpolarization. Both 
effects were transient and fading occurred during contact 
with the drug. When adenosine was added twice at an 
interval of 10 minutes, the second application had no or 
only a slight effect (Regenold and Illes, 1990). Similarly 
in the present electrophysiological study adenosine lost 
its effect with repeated application in low calcium medium.
Lee et al. (1986) showed that a brief period of global 
CNS anoxia resulted in a persistent down-regulation of 
[ H]CHA binding sites in the CA1 hippocampal pyramidal cells 
but not in the neocortex or striatum of gerbils. This was 
later shown however, to be preceded by an up-regulation of 
adenosine receptors (Kato et al . , 1991) within 1 hour of
recirculation. The relationship between this work and the 
present study is unclear, but ischemia may have profoundly 
different effects from the removal of calcium. In addition, 
the receptors studied here are restricted to the 
postsynaptic neuronal surface, whereas the changes 
occurring in anoxia may be far more diffusely distributed.
Despite these various studies, no desensitization to 
adenosine has previously been reported in 
electrophysiological investigations in the hippocampus.
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Indeed, Thompson et al, ( 1992) specifically emphasised that 
with intracellular recordings from hippocampal pyramidal 
cells (in normal bathing medium) no decline of sensitivity 
could be detected following the repeated application of 50 
pM adenosine over several hours. In this as in most earlier 
studies, however, the use of intrasomatic recordings would 
have detected primarily actions of adenosine exerted 
directly on the cell body. Dendritic responses would be 
less apparent, yet it is now recognized that dendritic 
receptors for adenosine do exist (Tetzlaff et al., 1987), 
linked to potassium and chloride channels. The use of
extracellular recordings of epileptiform activity in the 
present study should allow any contribution of dendritic 
receptors to overall neuronal excitability to be observed. 
However, a direct examination of somatic and dendritic 
sensitivity revealed that adenosine lost its activity in
calcium-free medium, when applied locally to either site.
It is therefore concluded that adenosine receptors are 
similarly affected by calcium-free media along the length 
of the pyramidal neurone. This also strengthens the view 
that it is the loss of divalent cations which induces 
desensitization, and not the manner of recording (i.e.
extracellular recording of secondary spikes rather than 
intracellular recording as in the work of Thompson et al. 
(1992). In fact in normal ACSF, repeated application of 
adenosine (cumulative-concentration) or prolonged (60 
minutes) superfusion of 10 uM or high concentration (2 mM) 
did not desensitize. It should be noted, however, that in
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the presence of low concentrations of calcium, locally 
applied adenosine responses showed some tendency to 
desensitize in the dendrites compared with the cell-body. 
This may indicate slight differences in the receptors or 
associated ion channels in the two regions.
The mechanism of actions and sites of desensitization 
and receptor(s) involved in desensitization depend on 
factors like design of experiment and the tissue used. Loss 
of agonist effects may be related to down regulation of 
receptors, reduction of affinity of agonist to its binding 
site, uncoupling of receptor from G-protein or changes in 
the regulatory proteins and their effectors such as 
adenylate cyclase and ion channels. The emergence of 
desensitization here is difficult to explain, but may 
reflect a time-dependent change of receptor state (or G- 
protein coupling) to an inactive form in low
calcium. A change of this type has been characterized for 
GABA, intracellular calcium promoting a decrease of 
receptor affinity for GABA in bullfrog sensory neurones 
(Inoue et al. , 1986). Previously reported desensitization
to adenosine of neuronal tissue, indicated no change of G- 
protein or adenylate cyclase subunit function (Porter et 
al., 1987; Abbracchio et al., 1992). In other tissues the
results are controversial. In rat adipocyte tissue, Gjaj and 
G-a2 but not G-a3 significantly decreased and GSQ increased 
following desensitization with a 6 day application of R-PIA 
(Longabaugh et al ., 1989). However in another in vivo
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experiment with 20 hours use of this Aj receptor agonist 
Stoneham (1989) could not duplicate the above results in 
rat adipose tissue. In smooth muscle, a down-regulation of 
G. protein and adenylate cyclase were seen to accompany the
u
desensitization of the A2 receptor system in porcine 
coronary artery (Hussain & Mustafa, 1993). In contrast, in 
rat aorta smooth muscle Anand-Srivastava et al (1989) 
showed that desensitization of NECA-sensitive adenylate 
cyclase may not be due to the decrease in activity of the 
catalytic subunit or of guanine nucleotide regulatory 
protein.
It has been reported that some occlusion occurs 
between adenosine and baclofen responses which might 
indicate the involvement of a common potassium channel or 
G-protein in hippocampal (Nicoll, 1988) or neocortical 
neurones (McCormick & Williamson, 1989). During the lack of 
response to adenosine in calcium-free medium, baclofen
still was active to decrease or abolish the secondary 
spikes. This would imply that either adenosine and baclofen 
are not acting via common potassium channels in the
hippocampal CA1 cells, or that desensitization is 
independent of ion channels and is confined to adenosine 
receptors or G-protein coupling. In fact the results 
showing different interactions of tolbutamide and
levcromakalim with adenosine and baclofen indicate that the
postsynaptic activity of these agonist are different (see 
section 4.3. for more explanation). Thus it may be possible
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that the ionic channels related to adenosine function might 
be involved in desensitization.
4.1.9. ROLE OF CARBAMAZEPINE AND PROCAINE ON ADENOSINE 
SENSITIVITY IN CALCIUM-FREE MEDIUM
One extracellular role of calcium is its stabilising 
action on cell membranes. Thus two stabiliser agents, 
procaine, a local anaesthetic and the anticonvulsant drug 
carbamazepine were examined. Carbamazepine and local 
anaesthetics possess in common the ability to block 
voltage-dependent sodium channels (Catterall, 1987; Zimanyi 
et a l . , 1989). Accordingly both were able to reduce or
abolish the neuronal spikes.
Using autoradiographic techniques in rat brain Worley 
and Baraban (1987) showed that the anticonvulsants 
phenytoin and carbamazepine interact allosterically with 
scorpion venom batrachotoxin (BTX) binding to sodium 
channels. Electrophysiologically they also demonstrated 
that the synaptic block of orthodromic population spikes in 
the rat hippocampus produced by the sodium channel 
activators, aconitine and veratridine, was inhibited by 
phenytoin and carbamazepine but not other anticonvulsants 
such as diazepam and phenobarbital which did not affect the 
venom binding. Willow et al. ( 1984) showed that
carbamazepine also blocked the influx of sodium into 
neuroblastoma cells and rat brain synaptosomes elicited by
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batrachotoxin (which activates sodium channels). Local 
anaesthetics such as tetracaine and procaine also bind to 
discrete site(s) on sodium channels, which results in block 
of the channels and allosteric inhibition of BTX binding. 
Their mechanism of action involves, at least in part, high- 
affinity binding to inactivated states of sodium channels 
(Postma and Catterall, 1984).
At concentrations of either agent which produced only 
a small depression of these potentials, carbamazepine and 
procaine, yielded a markedly synergistic interaction in 
combination with adenosine,. This may indicate that a 
partial blockade of sodium conductance is sufficient to 
restore adenosine sensitivity and, conversely, that the 
loss of potency in calcium-free media may be attributable 
to the increased sodium current. Potentiation cannot simply 
be the result of combining two inhibitory agents by 
different mechanisms, since the effect of baclofen was not 
enhanced in the presence of carbamazepine and also baclofen 
did not restore the inhibitory effect of adenosine.
This result is reminiscent of that reached by Ribeiro 
and Sebastiao (1984) using preparations of peripheral 
nerve. In a de-sheathed preparation of the frog sciatic 
nerve, these authors found that adenosine normally had no 
effect on action potential size. When voltage-dependent 
sodium channels were partially blocked by tetrodotoxin, 
however, adenosine was able to decrease action potential 
size.
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An important influence of sodium conductance is also 
indicated by direct measurements of extracellular ionic 
concentrations with ion-selective electrodes during 
superfusion of hippocampal slices with low calcium media. 
Under these conditions, as mentioned before, there is a 
significant decrease of extracellular sodium concentration, 
consistent with a massive influx of this ion into the 
intracellular compartment (Heinemann et al . , 1992; Yaari et 
al., 1983).
The mechanism linking blocking of sodium channels and 
restoration of adenosine sensitivity is not clear. 
Biochemical studies have shown that sodium chloride can 
decrease binding of adenosine (Johansson et al., 1992;
Stiles, 1988). There is probably a regulatory site for Na+ 
ion on the aspartate residue in Aj and A2 receptors 
(Jacobson et al., 1993b). This regulatory site for sodium 
was also observed for a-adrenergic and the dopamine D2 
receptor, located in the cytosol (Horstman et al. , 1990;
Motulsky & Insel, 1983; Neve et al . , 1991). Thus one
possibility is that during calcium-free bursts, the 
development of high concentrations of intracellular sodium 
modulate adenosine sensitivity. The calcium ions present in 
the extracellular medium interact with the external surface 
of the cell membrane. This interaction is due both to 
electrostatic attraction of ions by fixed anionic groups 
and to the binding of ions to such groups. Thus the maximal 
amplitude of inward sodium current induced by membrane
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depolarization can be influenced by calcium. A reduction of 
external calcium increases the sodium influx and vice versa 
(Kostyuk & Krishtal, 1977; Kostyuk, 1992). In fact with 
removal of calcium, sodium can pass through calcium 
channels (Frankenhaeuser & Hodgkin, 1957). Magnesium can 
also block calcium channels and thus affect sodium influx 
(Vormann & Gunther, 1993). Therefore part of the mechanism 
of these ionic effects on restoration of adenosine 
sensitivity in calcium-free media may be related to a 
decrease of sodium channel function.
It is not likely that the mechanism of this is 
activation of the sodium/ potassium exchanger by the 
increased sodium influx, leading to an increase of 
extracellular potassium and a loss of potassium gradient 
(although this does occur: Heinemann et al. , 1992; Yaari et 
al., 1983), since baclofen, like adenosine is believed to 
act by increasing potassium conductance and yet it is still 
effective under the conditions of our experiments.
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4.2. P A R A D O X I C A L  E F F E C T  OF M E T H Y L X A N T H I N E S  IN C A L C I U M - F R E E
M E D I A
The idea for using adenosine antagonists emerged from 
the restoration of adenosine sensitivity in calcium-free 
medium by carbamazepine. Since carbamazepine may be an 
adenosine antagonist (Skerritt et al. , 1983a,b; Stone,
1988), xanthine adenosine antagonists, theophylline and 
cyclopentyltheophyl1ine, were used.
In the present study theophylline showed two opposite 
effects, an expected excitatory one when examined with 
orthodromic stimulation in normal ACSF, but an inhibitory 
one when tested on responses to antidromic stimulation in 
calcium-free medium.
The results of antidromic stimulation in the presence 
of normal calcium and bicuculline to induce bursts showed 
that theophylline did not decrease the potential size. Thus 
the nature of the stimulation determines the inhibitory 
effect of theophylline, ie. calcium-free medium is 
essential for theophylline to exert an inhibitory effect.
Alkylxanthines such as theophylline and caffeine have 
a variety of actions in the central nervous system or 
peripheral tissues. These agents are antagonists at the Aj 
and A2 subtypes of adenosine receptor (Daly et al. , 1981;
Greene et al. , 1985), and they inhibit activation of
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enzymes like phosphodiesterase (Butcher & Sutherland, 1962; 
Fredholm et al., 1978), 5'-nucleotidase and alkaline
phosphatase (Fredholm et al. , 1978). In addition, the
2+
xanthines stimulate Ca release from internal stores (Lee, 
1993; Tanaka & Tashjian, 1993). Uneyama et al. , (1993) have 
also now shown that methylxanthines can block glycine- and 
GABA-gated chloride currents in freshly dissociated rat 
hippocampal neurones.
Adenosine normally acts at Al receptors to induce an 
inhibition of neuronal excitability. This is often seen as 
a reduced release of neurotransmitters, especially of 
excitatory agents such as acetylcholine (Brown et a l ., 
1990b; Spignoli et al., 1984) and glutamate (Corradetti et 
al . , 1984; Fastbom et al. , 1985; Lambert & Teyler, 1991),
but is also seen as an increase of potasssium conductance 
(Haas & Greene, 1984). Adenosine antagonists, therefore, 
including xanthines, usually exert excitatory actions on 
the nervous system, including an increase in the release of 
transmitters and an increase in the size of synaptic 
potentials (Bauman et al., 1992). The epileptogenic
activity of xanthines is believed due to the block of 
adenosine receptors, since adenosine blocks the excitatory 
or seizure discharge induced by alkylxanthines in the 
hippocampus of the guinea pig in vitro (Okada & Ozawa, 
1980). Theophylline has been shown to increase the 
frequency of epileptiform bursts of action potentials in 
the hippocampal slice (Dunwiddie, 1980; Dragunow et a l . ,
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1985; Dragunow, 1988), while the Al selective antagonist
1,3-dipropyl-8-cyclopentylxanthine causes the development 
of abnormal excitability in vitro which can far outlast the 
duration of application (Alzheimer et al. , 1989a, 1993). In 
vivo, cyclopentyltheophyl1ine has been found to induce 
status epilepticus in vivo in animals subjected to 
electrical stimulation (Young & Dragunow, 1994).
At sites such as the neuromuscular junction xanthine 
also have excitatory effects -leading to an increased 
release of acetylcholine (Ribeiro & Sebastiao, 1987).
Lowering the extracellular concentration of calcium in 
media perfusing brain slices blocks synaptic transmission, 
but leads to the development of bursts of action potentials 
(Taylor & Dudek, 1982; Haas & Jefferys, 1984). The 
mechanisms proposed to account for this include loss of the 
screening action of calcium on surface membrane charges, 
the result of which is a destabilisation of the membrane 
(Frankenhauser & Hodgkin, 1957; Agrigoroaei & Neacgu,
1990), and the loss of tonically active potassium 
conductances which are normally dependent on calcium influx 
(Agopyan & Avoli, 1988). Nevertheless it seems likely, from 
the present results, that a small amount of extracellular 
calcium is needed to maintain epileptiform firing, since 
inclusion of EGTA in the bathing medium reduces the size of 
the recorded population spikes.
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One possible explanation of the results presented 
here, therefore, may be that, under conditions of low 
calcium-induced membrane instability the xanthines displace 
calcium bound to phospholipids in the neuronal membrane, 
thus mimicking the effect of EGTA and reducing 
excitability. This idea is supported by the fact that CPT 
and EGTA had an additive effect on spike size, and the fact 
that adding 100 pM calcium diminished the depressant effect 
of theophylline. Presumably such a displacement of calcium 
_would occur primarily on or near the outer face of the cell 
membrane to induce the observed depression of excitability.
Adenosine can limit the influx of calcium stimulated 
by potassium or veratridine into neurones (Wu et al. , 
1982). Using ion-selective electrodes it has been 
demonstrated that adenosine can decrease the movements of 
calcium ions into both presynaptic and postsynaptic sites 
in the hippocampal slice (Schubert et al ., 1986; Schubert, 
1992). Conversely, the selective Al receptor antagonist CPX 
enhanced stimulus train induced calcium influx in the 
synaptic and pyramidal cell body layers of the slices 
(Schubert, 1988). Inhibition of calcium movements therefore 
represents one possible mechanism by which adenosine could 
block the xanthines.
Although the precise relationship is not clear, it is 
possible that the depressant effect of xanthines observed 
here may be similar in mechanism to that reported by
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Ribeiro and Sebastiao (1984). These authors found that 
xanthines shared the ability of adenosine to block action 
potential production of frog sciatic nerves partially 
poisoned by tet rodotoxin. To date that report and the 
present study are among very few to show qualitatively 
similar neuronal depressant effects of xanthines.
The mechanism by which baclofen was able to prevent 
the depressant effect of theophylline on population bursts 
may be related to the movement of calcium postulated above-. 
Gahwiler and Brown (1985) had failed to detect any effect 
of baclofen on calcium currents in CA3 neurones recorded in 
organotypic slice cultures of the hippocampus. However, 
baclofen was later reported to block calcium conductances 
on dorsal root ganglion neurones (Dolphin & Scott, 1987), 
and a similar action was observed subsequently by Scholz & 
Miller (1991b) using dissociated embryonic cells from the 
hippocampus. It is possible to speculate, therefore, that 
baclofen restricts the xanthine-induced movement of 
residual calcium across the neuronal membrane.
Since a major action of baclofen on central neurones 
is to open potassium channels (Thompson & Gahwiler, 1992), 
this might represent an alternative means by which the 
agonist could interact with theophylline. This idea is made 
attractive by recent evidence that theophylline can 
activate three types of potassium current, at least one of 
which remains active in the absence of external calcium,
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(Munakata & Akaike, 1993) and which could therefore mediate 
the inhibitory activity of xanthines described here. 
However, the concentrations of theophylline used to 
activate these potassium channels were one to two orders of 
magnitude greater than the levels used here. In addition, 
it might be expected that the combination of theophylline 
and baclofen would be at least additive in producing an 
inhibition of neuronal excitability by a similar mechanism, 
whereas baclofen actually abolished the response to 
theophylline alone.
The anticonvulsant drug carbamazepine also proved able 
to prevent the inhibitory activity of theophylline on 
evoked action potential bursts. This may reflect 
carbamazepine’s ability to block neuronal sodium currents 
(Catterall, 1987), thus acting to stabilise the membrane 
in a manner comparable with the addition of 100 uM calcium. 
Alternatively, since carbamazepine has been claimed to 
suppress calcium channels in ganglion cells (Schirrmacher 
et al . , 1993) and guinea-pig hippocampal slices (Walden et 
al ., 1993) it is possible that, like baclofen, the drug is 
acting by preventing xanthine induced movements of calcium.
Another different mechanism of the xanthines may be 
related to inhibition of phosphodiesterase and increase of 
cAMP (Butcher & Sutherland, 1962; Fredholm et al . , 1978),
although the concentrations of these agents were very low 
for this effect. In fact an elevation of cAMP in neurons in
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response to neurotransmitters can modulate Na+ channel 
function (Li et a l ., 1992). All agents, adenosine (via Aj
receptor, Londos et al. , 1980; Van Calker et al. , 1979), 
baclofen (Wojcik & Neff, 1984) and carbamazepine (Lewin & 
Bleck, 1977) can decrease levels of cAMP and could thus 
counteract these effect of theophylline or CPT.
The isolation of CA1 from CA3 also showed that the 
possible induction of spontaneous activity by the xanthines 
could not be the reason for their inhibitory effects.
Although CPT more potently antagonized the inhibitory 
effect of adenosine on orthodromic population spikes than 
theophylline, the xanthines were equally effective in 
suppressing antidromic bursts in calcium-free medium. This 
result may imply that this inhibitory effect is not related 
to the blockade of adenosine receptors. The fact that 
adenosine deaminase could not prevent the effect of 
theophylline also supports this idea.
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4.3. DIFFERENT SENSITIVITY OF ADENOSINE AND BACLOFEN TO 
POTASSIUM CHANNEL BLOCKERS OR OPENERS
The reason that the GABAg agonist baclofen is clearly 
able to depress antidromic spikes, but adenosine cannot is 
not fully clear. One of the differences between adenosine 
and baclofen is in the location of their receptors. 
Baclofen (GABAg) receptors are located on both excitatory 
and inhibitory presynaptic elements and can reduce the 
amplitude of monosynaptic IPSPs in the presence of 
excitatory amino acid receptor antagonists (Thompson & 
Gahwiler, 1992). On the contrary, adenosine receptors are 
located on excitatory, but not inhibitory, presynaptic 
elements and have no effect on the monosynaptic IPSPs 
(Lambert & Teyler, 1991; Thompson et a l ., 1992; Yoon &
Rothman, 1991).
At the presynaptic sites, both agents decrease EPSPs, 
an effect which is blocked by activation of PKC by phorbol
esters. Inhibition of EPSPs was not changed by pertussis
2 +toxin or Ba (Thompson & Gahwiler, 1992; Thompson et al.,
1992).
At the postsynaptic site, which is the main focus of 
the present, the inhibitory actions of these agents mainly 
are attributable to hyperpolarization induced by activation 
of potassium channels (Gahwiler & Brown, 1985; Newberry & 
Nicoll, 1984; Thompson & Gahwiler, 1992 for baclofen;
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Greene & Haas, 1985; Okada & Ozawa, 1980; Segal, 1982; 
Thompson et al. , 1992, for adenosine). There are some
reports that adenosine can also induce a steady-state 
inward current involving a voltage-dependent chloride 
conductance (Mager et al., 1990, Schubert et al., 1991). In 
the CNS, the type of potassium channels activated by 
adenosine and baclofen, however, are controversial. Barium 
can block the adenosine- (Gerber et a l ., 1989; Thompson et 
al. , 1992) and baclofen- (Gahwiller & Brown, 1985; Misgeld 
et al ., 1989; Thompson & Gahwiler, 1992) activated
potassium conductance in the rat hippocampus but barium has 
a variety of effects including blocking several different 
potassium currents such as 1^ , I^TP and iy (Cook, 1988; 
Quayle et al., 1988). This does not necessarily imply that 
the same potassium channels are involved. The present 
results with tolbutamide and antidromically evoked 
potentials clearly showed that the postsynaptic effect of 
adenosine and baclofen are different since the inhibitory 
effect of adenosine on secondary spikes was almost 
abolished by tolbutamide while this compound had no effect 
on baclofen sensitivity. This also suggests that the 
effects of adenosine may involve channels.
4-Aminopyridine (4-AP): 4-AP is an aminopyridine which 
is one of the most commonly used group of potassium channel 
blockers (Cook & Quast, 1990). Depending on the 
concentration, 4-AP blocks different potassium channels. In 
the hippocampus, it blocks Ip, a slowly inactivating
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potassium current, at low concentration (30 pM) (Storm, 
1988), and IA, a fast transient potassium current, at high 
concentration (1-5 mM) (Storm, 1990). 4-AP at 5mM had no 
effect on 1^ , the delayed rectifier potassium current in the 
hippocampus (Rudy, 1988). 4-AP at millimolar levels also 
blocked KATp in skeletal and heart muscle (Castle & Haylett, 
1987; Haworth et al., 1989; Kakei et a l ., 1985)By blocking 
the potassium channel, 4-AP can affect membrane 
repolarization and result in prolonged action potentials 
and increased transmitter release and induced synchronous 
burst discharges (Clark & Wilson, 1992; Voskuyl & Albus, 
1985) .
Gerber et a l . ( 1989) reported that adenosine had no
effect on a 4-aminopyridine (4-AP) sensitive transient (IA) 
and tetraethylammonium (TEA) sensitive delayed (1^ ) outward 
currents on hippocampal neurones, but in several areas of 
brain including the hippocampus (Schubert & Lee, 1986), 
cerebral cortex (Perkins & Stone, 1980), olfactory cortex 
(Scholfield & Steel, 1988) and locus coeruleus (Pan et al . , 
1994) it has been reported that adenosine may activate IA- 
Recently Li and Henry (1992) reported that adenosine- 
induced hyperpolarization was depressed by glibenclamide, 
a blocker of ATP-sensitive K+ channels, in rat CA1 neurones.
.There are also some reports that GABAg receptors may 
activate IA in hippocampus (Inoue et al . , 1985; Saint et
al . , 1990) or activate KA-j.p in substantia nigra neurones
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(Roeper et al., 1990), although Solis and Nicoll (1992)
found that 4-AP at concentrations up to 1 mM did not block 
baclofen induced outward currents in rat hippocampus.
With intracellular recording in the rat hippocampus, 
in the presence of 4-AP, adenosine still produced its 
typical hyperpolarization (Segal, 1982; Greene & Haas,
1985). 4-AP at high concentration (5mM) blocked the 
inhibitory effect of adenosine on CA1 neurones, although 50 
pM adenosine showed no increase of- IA in rat hippocampus 
slices (Gerber et al. , 1989). R-PIA, a stable derivative of 
adenosine, with high concentration, 5 pM, had low potency 
against the 4-AP (100 jiM) epileptiform bursting. In 
contrast to the negative interaction between adenosine and 
4-AP, Scholfield and Steel (1988) in olfactory cortex of 
guinea pigs demonstrated that adenosine enhances an
aminopyridine-sensitive potassium conductance in nerve
2 +terminals. Application of high Mg or low concentrations of 
tetrodotoxin abolished the increased excitability but still
3,4-diaminopyridine blocked the adenosine action. These 
observations suggest that the action of the aminopyridine 
on adenosine was not solely the result of increased tissue 
exci tabi1i ty.
Because of the structural similarity of adenosine and 
4-AP, the possibility of an interaction between adenosine 
and 4-AP at receptor sites was suggested by Perkins and 
Stone (1980). With a radioligand receptor binding study in
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the rat striatum, Drukarch et al.,(1989) also showed that
3
4-AP could antagonize muscarinic receptor ligand, [ H]- 
dexetimide, <Xj-, a2~ and 3~adrenoceptor radioligand, Dj-, D2~ 
, 5HT1A~, and 5HT2~ receptor ligand binding at receptor
sites.
250 pM 4-AP completely abolished the inhibitory effect 
of 50 pM adenosine on the fEPSPs in the rat hippocampus 
slices. This failure of adenosine to counteract 4-AP may be 
related to a saturation of the release process by calcium 
in -such a way that the effects of adenosine are masked 
(Dunwiddie et al. , 1991). Klapstein and Colmers ( 1992)
studied the presynaptic effect of 2-chloradenosine, 
neuropeptide Y (NPY) and baclofen on the rat hippocampus. 
4-AP (30 and 100 pM) reduced the inhibitory effect of these 
compounds on EPSP slope. Low calcium medium (0.75 mM) and 
the presence of 30 pM 4-AP, restored the effect of NPY and 
baclofen but not 2-chloradenosine. The authors concluded 
therefore that presynaptic NPY Y2 and GABAg receptors both 
inhibit transmitter release by inhibition of voltage 
dependent calcium influx but Aj adenosine receptors may 
affect on a different presynaptic mechanism. Thus these 
result show different sensitivity of adenosine and baclofen 
to 4-AP.
In general it seems that in those experiments which 
have been done in the presence of calcium, interaction of 
adenosine with 4-AP is indirect and may be related to a 
large release of excitatory amino acids which increase
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general excitability. In the experiment of Klapstein and 
Colmers (1992), which used low calcium and 4-AP, so that 
neurotransmission continued, it is not posssible to exclude 
this possibility. Another possibility in relation to the 
interaction of adenosine with 4-AP may be related to the 
fact that use of high concentration of this potassium 
channel blocker may block KATp as well.
4.3.1. EFFECT OF APAMIN ON THE INHIBITORY EFFECT OF 
ADENOSINE ON ORTHODROMIC POPULATION SPIKES
One possible explanation for the loss of adenosine 
sensitivity is that calcium removal results in the loss of 
ionic conductances needed for the effect of adenosine. If 
adenosine enhances the activation of calcium-activated 
potassium conductances, this will not be operating in the 
absence of external calcium. Adenosine increased the slow 
AHP produced by increased potassium conductance (Gerber et 
al., 1989; Greene & Haas, 1985). Apamin is known to block 
the slow calcium-activated potassium current or IABp 
(Halliwell, 1990). Thus to study whether adenosine acts 
through this potassium current, the interaction of 
adenosine with apamin was studied.
Apamin is a bee venom which constitutes 2 % dry weight 
of the venom. Other toxic peptides of the venom are 
melittin and mast cell degranulating (MCD) peptide 
(Habermann, 1984). Apamin is an octadecapeptide, slightly
177
smaller than MCD peptide but of remarkably similar 
structure, with two intramolecular disulphide bridges and 
aminated C-terminal carboxyl group (Strong, 1990). It is 
the unique neurotoxic polypeptide known to pass the blood- 
brain barrier (Cavey et al. , 1978). Apamin is a centrally
acting peptide neurotoxin that produces motor hyperactivity
2+and convulsions. This toxin blocked the slow Ca -activated 
K+ channel in different tissues such as neocortex (Szente et 
a l ., 1988), neuroblastoma and rat muscle cells (Lazdunski
et al. , 1985), sympathetic ^ neurones (Kawai & Watanabe,
1986) and ganglion cells (Goh & Pennefather, 1987; 
Nishimura et al ., 1988).
With the voltage clamp technique, the slow AHP of rat 
hippocampus (Storm, 1990) and guinea pig olfactory cortex 
neurones (Constanti and Sim, 1987) was insensitive to 
apamin. Howevere, in view of the existence of apamin 
sensitive channels with high density in the hippocampus 
demonstrated by autoradiographic technique (Janicki et a l . , 
1984; Ikeda et a l . , 1991; Mourre et al. , 1986) it is not
clear why apamin could not block this channel in these 
studies. In the present study also apamin did not have a 
consistent effect on the field potential and in two slices 
had no effect. These results may be related to the nature 
of some peptides that may be inactivated or may be adsorbed 
to airstone > tubes or other parts of the experimental 
appartus.
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Apamin did not block the inhibitory effect of 
adenosine on orthodromic population spikes in this study. 
Apamin at low concentration blocked the relaxant effect of 
ATP and ADP (Brown & Burnstock, 1981) and NADP (Burnstock 
& Hoyle, 1985) but not adenosine and AMP on the carbachol 
contracted taenia coli of the guinea pig (Brown & 
Burnstock, 1981). Adenosine-activated potassium current in 
smooth muscle cells isolated from the pig coronary artery 
also were not blocked by apamin (Dart & Standen, 1993). 
Because of the high cost of apamin and the preliminary 
negative results, interaction of this peptide with 
adenosine was not studied antidromic bursts.
4.3.2. ROLE OF KATp IN HYPERPOLARIZATION EFFECT OF ADENOSINE 
AND BACLOFEN
The present results suggest KATp channel involvement in 
the postsynaptic effect of adenosine and are consistent 
with a report that an inhibitory postsynaptic potential in 
spinal nociceptive neurones, apparently mediated by 
adenosine, was blocked by glibenclamide (Salter et al.,
1993). The present result is also consistent with the block 
of adenosine-induced hyperpolarization by glibenclamide in 
the hippocampus (Li & Henry, 1992) and a report that in rat 
ventricular myocytes ATP-sensitive K+ channels are coupled 
to adenosine Aj receptors by G- (Kirsch et al . , 1990). It
has been suggested that the activation of this K+ channel 
may be involved in vasodilation or vasodepression by
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adenosine (Dart & Standen, 1993; Furukawa et a l . , 1993)
although in the pithed rat, no role for gl i bene 1 amide- 
sensitive potassium channels was seen in the action of 
adenosine Aj and A2 receptor agonists on the cardiovascular 
system (Fozard & Carruthers, 1993b).
The lack of KATp involvement in the activity of baclofen 
is consistent with behavioural evidence that, although KATp 
channel activation can cause antinociception (Narita et 
a l . , 1993) the antinociceptive effect of baclofen is not
prevented by gliquidone, a potent KATp channel blocker (Ocaria 
& Baeyens, 1993).
The fact that tolbutamide had no effect on the 
presynaptic action of adenosine may indicate a totally 
different mechanism for the pre- and postsynaptic effects. 
The possible existence of different types of potassium 
channels activated by adenosine at pre- and postsynaptic 
sites cannot be excluded.
The results of using levcromakal im, a KATp opener, also 
revealed a different sensitivity of adenosine and baclofen 
inhibitory actions. In cultured rat hippocampal neurones, 
glibenclamide produced a concentration-dependent depression 
of the cromakalim-activated current and single-channel 
recordings showed that similar channel openings by 
cromakalim were observed in patches from cells exposed to 
energy-depleting conditions induced by oligomycin and 2-
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deoxy-D-glucose. Glibenclamide inhibited channels activated 
both by cromakalim and energy-depleting conditions (Politi 
& Rogawski, 1991). In another study in hippocampal 
neurones, Tromba et al. (1992) showed KATp activity which was 
regulated by extracellular glucose. These channels were 
open in resting cells and were inhibited by glibenclamide 
and activated by levocromakalim. In CA3 neurones of the 
guinea-pig hippocampus in vitro, Alzheimer et al. (1989b)
showed that the cromakalim-activated potassium channel 
causes inward rectification and among a number of potassium 
channel blockers as well as tolbutamide, only caesium and 
barium were able to inhibit the cromakalim-induced effects. 
Also using patch clamp techniques on frog skeletal muscle, 
Quayle et a l . (1988) showed that barium and caesium can
block the ATP-sens i t ive K+ channel. In this study 
levcromakalim reduced the excitatory effect of tolbutamide 
by about 50% although this was not statistically 
significant. It is possible that these agents have effects 
on different potassium channels besides KATp.
In isolated substantia nigra neurones, tolbutamide has 
been claimed to reverse membrane hyperpolarization induced 
by activation of dopamine D2 receptors and GABAg receptors 
(Roeper et al . , 1990), although in the same brain region
Hicks and Henderson (1992) used applications of tolbutamide 
or gl ibenclamide and concluded that the D2 receptor does not 
show the pharmacological characteristics of an ATP- 
sensitive potassium conductance. The GABAg receptor was not 
studied by this group.
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When a maximal hyperpolarization response had been 
evoked with baclofen, Nicol (1988) found that adenosine was 
unable to produce any additional response. It was proposed 
that the receptor mechanisms activated by the two agonists 
might converge onto a common potassium channel. A similar 
proposal was made as a result of studies on cells in the 
cerebral cortex (McCormick & Williamson, 1989). Although 
this conclusion differs from that drawn from the present 
work, it may be related to the use of maximal 
concentrations of agonists by these authors. In particular, 
maximal concentrations may recruit a population of 
potassium channels which can be activated by both agents 
and mask the differential activation of separate channels 
seen in the present work.
Finally, a totally different explanation of these 
results should be considered. Sulphonylurea compounds which 
block KATp channels can also release glutamate (Kwiecien et 
al . , 1993; Zini et al . , 1993). The release of glutamate
might activate the population of receptors sensitive to N- 
methy1-D-aspartate (NMDA), an action which has been found 
to diminish responses to adenosine (Bartrup & Stone, 1990; 
Bartrup et al., 1991). However kynurenic acid, the
excitatory amino acid antagonist at high concentration (5 
mM) had no effect on antidromic action potential bursts 
induced by calcium-free media. Thus the activation of NMDA 
channels or glutamate release by tolbutamide and consequent 
suppression of adenosine sensitivity is unlikely. In
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addition, such an explanation would be expected to diminish 
the presynaptic effect of adenosine (effect on fEPSPs). as 
reported previously (Bartrup & Stone, 1990; Bartrup et al.,
1991), whereas this was not observed in the present work.
The results of interaction of adenosine and the two 
stabilising agents suggest two conclusions. Firstly, it is 
clear that adenosine can still cause neuronal inhibition 
even in the absence of extracellular calcium, provided that 
sodium conductance is limited. Secondly, in the central 
nervous system as in the periphery, adenosine has 
inhibitory effects which are in part determined by the 
state of voltage-dependent sodium channels or the extent of 
sodium influx across the membrane. It is possible that, 
based on the results described here, interactions involving 
synergistic inhibitions between carbamazepine and 
endogenous adenosine could contribute to the anticonvulsant 
activity of carbamazepine and related agents.
The xanthines theophylline and CPT depressed the 
excitability of hippocampal pyramidal neurones in calcium- 
free media. This effect was prevented by adenosine, which 
had no effect by itself, but was not reproduced or modified 
by adenosine deaminase. The xanthine effects were also 
prevented by baclofen and carbamazepine. A common feature 
of adenosine, baclofen and carbamazepine which may account 
for their antagonism of the xanthines is the blockade of 
calcium channels or inhibition of cAMP. It is therefore
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proposed that in the presence of low external 
concentrations of calcium xanthines can reduce excitability 
by promoting the movement of residual calcium in the medium 
or neuronal membranes.
With respect to the different sensitivity of adenosine 
and baclofen to calcium-free medium and a potassium channel 
blocker (tolbutamide) or opener (levcromakalim) it is 
concluded that the mechanisms of postsynaptic activity of 
adenosine and baclofen are clearly different and at 
postsynaptic, but not presynaptic, sites adenosine may 
activate ATP (tolbutamide or cromakalim)-sensitive 
potassium channels. The results of using procaine, 
carbamazepine and the adenosine binding enhancer (PD81723) 
also showed that the requirement of calcium for the 
postsynaptic effects of adenosine in calcium-free medium 
may be indirect and related to its stabilising action.
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